Schwazze Closes Acquisition Of Emerald Fields



Schwazze Closes Acquisition Of Emerald Fields

Research, News, and Market Data on Schwazze

 

Schwazze Continues Colorado Expansion Strategy with
Emerald Fields Cannaboutique Dispensaries in Manitou Springs & Glendale, CO

DENVER, CO – February 10, 2022 – Schwazze, (OTCQX:SHWZ) (“Schwazze” or the “Company”), announced today that it has closed the transaction to acquire MCG, LLC (“Emerald Fields”). Emerald Fields is the owner and operator of two retail cannabis dispensaries, located in Manitou Springs and Glendale, Colorado. This successful acquisition is part of the Company’s ongoing retail expansion plan in Colorado and New Mexico, bringing the total number of dispensaries the Company operates to 32.

Total consideration for the acquisition is $29 million and will be paid as 60% cash and 40% Schwazze common stock upon closing. This is an estimated 3.8 multiple on 2021 Adjusted EBITDA(1).

“Our team is delighted to add the Emerald Fields Cannaboutiques to our growing portfolio of dispensaries and are eager to welcome the team to Schwazze. Manitou Springs and Glendale are attractive locations and valuable assets to our overall growth plan as we continue to build out Colorado. Our team is excited to add another store brand to our house of brands.” said Justin Dye, Schwazze’s CEO.

About Schwazze

Schwazze (OTCQX: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.

Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

Forward-Looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,”, “predicts,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, (x) the timing and extent of governmental stimulus programs, (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws, and (x) out ability to satisfy the closing conditions for the private finding described in this press release. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

(1) Adjusted EBITDA represents income (loss) from operations, as reported, before tax, adjusted to exclude non-recurring items, other non-cash items, including stock-based compensation expense, depreciation, and amortization, and further adjusted to remove acquisition related costs, and other one-time expenses, such as severance. The Company uses adjusted EBITDA as it believes it better explains the results of its core business. The Company has not reconciled guidance for adjusted EBITDA to the corresponding GAAP financial measure because it cannot provide guidance for the various reconciling items. The Company is unable to provide guidance for these reconciling items because it cannot determine their probable significance, as certain items are outside of its control and cannot be reasonably predicted. Accordingly, a reconciliation to the corresponding GAAP financial measure is not available without unreasonable effort.

Investors
Joane Jobin
Investor Relations
Joanne.jobin@schwazze.com
647-964-0292

Media
Julie Suntrup, Schwazze
Vice President | Marketing & Merchandising
julie.suntrup@schwazze.com
303-371-0387

CoreCivic Reports Fourth Quarter and Full Year 2021 Financial Results



CoreCivic Reports Fourth Quarter and Full Year 2021 Financial Results

Research, News, and Market Data on CoreCivic

 

BRENTWOOD, Tenn., Feb. 09, 2022 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) announced today its financial results for the fourth quarter and full year 2021.

Financial Highlights – Full Year 2021

  • Total revenue of $1.86 billion
    • CoreCivic Safety revenue of $1.69 billion
    • CoreCivic Community revenue of $99.4 million
    • CoreCivic Properties revenue of $68.9 million
  • Net loss attributable to common stockholders of $51.9 million
  • Net loss reflects $178.6 million of special items, including $114.2 million of income taxes associated with change in corporate tax structure reflected in the first quarter of 2021
  • Diluted net loss per share of $0.43
  • Adjusted diluted EPS of $1.04
  • Normalized FFO per diluted share of $1.85
  • Adjusted EBITDA of $402.0 million

Damon T. Hininger, CoreCivic’s President and Chief Executive Officer, said, “Our fourth quarter financial performance capped off another year of resilient cash flow generation amid the ongoing global pandemic.   During 2021, we made great strides in enhancing our capital structure by revoking our REIT election, selling non-core assets which enabled us to accelerate our debt reduction strategy, accessed the debt capital markets, extended our debt maturities, and positioned our balance sheet to allow us to pursue attractive growth opportunities and return capital to shareholders. With the financial guidance we are providing today for the full year 2022, our capital allocation strategy remains on track.

Hininger continued, “We began 2022 on a positive note with the recent announcement of our new contract with the state of Arizona to care for up to 2,706 inmates at our La Palma Correctional Center, which is the largest contract awarded to the private sector by any state in over a decade.   We look to continue this positive momentum as we pursue other market opportunities that may present themselves throughout the year.”

Financial Highlights – Fourth Quarter 2021

  • Total revenue of $472.1 million
    • CoreCivic Safety revenue of $432.8 million
    • CoreCivic Community revenue of $25.3 million
    • CoreCivic Properties revenue of $14.0 million
  • Net income attributable to common stockholders of $28.0 million
  • Diluted earnings per share of $0.23
  • Adjusted diluted EPS of $0.27
  • Normalized FFO per diluted share of $0.48
  • Adjusted EBITDA of $103.2 million

Fourth Quarter 2021 Financial Results Compared With Fourth Quarter 2020

Net income attributable to common stockholders in the fourth quarter of 2021 totaled $28.0 million, or $0.23 per diluted share, compared with net loss attributable to common stockholders in the fourth quarter of 2020 of $26.8 million, or a net loss of $0.22 per diluted share. Adjusted for special items, net income in the fourth quarter of 2021 was $32.6 million, or $0.27 per diluted share (Adjusted Diluted EPS), compared with adjusted net income in the fourth quarter of 2020 of $48.8 million, or $0.40 per diluted share. Special items for each period are presented in detail in the calculation of Adjusted Diluted EPS in the Supplemental Financial Information following the financial statements presented herein. Financial results in 2021 reflect higher income tax expense following the revocation of our election to be taxed as a real estate investment trust (REIT) effective January 1, 2021. As a REIT, we were entitled to a deduction for dividends paid, which resulted in a significantly lower income tax expense in the prior year. The decline in per share amounts was also the result of property sales and refinancing transactions, both of which strengthened our balance sheet, as well as an increase in general and administrative (G&A) expenses.

Earnings before interest, taxes, depreciation and amortization (EBITDA) was $97.0 million in the fourth quarter of 2021, compared with $33.0 million in the fourth quarter of 2020. Adjusted EBITDA, which excludes special items, was $103.2 million in the fourth quarter of 2021, compared with $108.7 million in the fourth quarter of 2020. Adjusted EBITDA decreased from the prior year quarter due to the sale of 47 non-core real estate assets since the end of the third quarter of 2021, which generated $7.4 million in Adjusted EBITDA in the fourth quarter of 2020, and an increase in G&A expenses primarily resulting from lower incentive compensation in the prior year due to the onset of COVID-19.  

Funds From Operations (FFO) was $54.7 million, or $0.45 per diluted share, in the fourth quarter of 2021, compared to $22.8 million, or $0.19 per diluted share, in the fourth quarter of 2020. Normalized FFO, which excludes special items, was $57.8 million, or $0.48 per diluted share, in the fourth quarter of 2021, compared with $76.3 million, or $0.63 per diluted share, in the fourth quarter of 2020. FFO and Normalized FFO were also impacted by our new corporate tax structure.

Adjusted Net Income, EBITDA, Adjusted EBITDA, FFO, and Normalized FFO, and, where appropriate, their corresponding per share amounts, are measures calculated and presented on the basis of methodologies other than in accordance with generally accepted accounting principles (GAAP). Please refer to the Supplemental Financial Information and related note following the financial statements herein for further discussion and reconciliations of these measures to net income, the most directly comparable GAAP measure.

Business Updates

New Contract with the State of Arizona at the La Palma Correctional Center. On January 10, 2022, we announced that we were awarded a new contract with the state of Arizona to care for up to 2,706 adult male inmates on behalf of the Arizona Department of Corrections, Rehabilitation & Reentry (ADCRR) at the Company’s 3,060-bed La Palma Correctional Center in Eloy, Arizona. The new management contract has an initial term of five years, with one extension option for up to five years thereafter upon mutual agreement. We are currently working with ADCRR on a ramp plan that is expected to begin late in the first quarter or early in the second quarter of 2022. The La Palma facility currently supports the mission of Immigration and Customs Enforcement (ICE) by caring for approximately 1,800 detainees. We are simultaneously working with ICE to coordinate the transition of their populations to other facilities, including at facilities where we have available capacity within the region. We expect the transition of populations from ICE detainees to inmates from the state of Arizona to result in the disruption of earnings and cash flows until the occupancy of inmates from the state of Arizona reaches stabilization. Upon full utilization of the new contract with the state of Arizona we expect to generate approximately $75 million to $85 million in annualized revenue at the La Palma facility.  

2022 Financial Guidance

Based on current business conditions, the Company is providing the following financial guidance for the full year 2022:

  Full Year 2022
• Diluted EPS $0.72 to $0.86
• FFO per diluted share $1.55 to $1.70
• EBITDA $354.8 million to $370.0 million

Our 2022 guidance reflects a continuation of occupancy restrictions placed on our bed capacity by many of our government partners as a result of the ongoing COVID-19 pandemic, which could result in enhanced earnings when relieved. Our 2022 guidance also reflects the aforementioned transition of resident populations at our La Palma Correctional Center, and higher operating expenses due to above average wage inflation we expect to experience in 2022 as a result of the challenging labor market.

During 2022, we expect to invest approximately $75.8 million to $79.3 million in capital expenditures, consisting of approximately $33.8 million to $34.3 million in maintenance capital expenditures on real estate assets; $30.0 million to $32.0 million for capital expenditures on other assets and information technology and $12.0 million to $13.0 million for facility renovations.

Supplemental Financial Information and Investor Presentations

We have made available on our website supplemental financial information and other data for the fourth quarter and full year 2021.   Interested parties may access this information through our website at http://ir.corecivic.com/ under “Financial Information” of the Investors section.   We do not undertake any obligation and disclaim any duties to update any of the information disclosed in this report.  

Management may meet with investors from time to time during the first quarter of 2022.   Written materials used in the investor presentations will also be available on our website beginning on or about February 21, 2022.   Interested parties may access this information through our website at http://ir.corecivic.com/ under “Events & Presentations” of the Investors section.

Conference Call, Webcast and Replay Information

We will host a webcast conference call at 10:00 a.m. central time (11:00 a.m. eastern time) on Thursday, February 10, 2022, which will be accessible through the Company’s website at www.corecivic.com under the “Events & Presentations” section of the “Investors” page. The live broadcast can also be accessed by dialing 877-614-0009 in the U.S. and Canada, including the confirmation passcode 8591205. An online replay of the call will be archived on our website promptly following the conference call. In addition, there will be a telephonic replay available beginning at 1:15 p.m. central time (2:15 p.m. eastern time) on February 10, 2022, through 1:15 p.m. central time (2:15 p.m. eastern time) on February 18, 2022. To access the telephonic replay, dial 888-203-1112 in the U.S. and Canada. International callers may dial +1 719-457-0820 and enter passcode 8591205.

About CoreCivic

CoreCivic is a diversified government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. CoreCivic provides a broad range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address America’s recidivism crisis, and government real estate solutions. CoreCivic is the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and believes it is the largest private owner of real estate used by government agencies in the U.S. CoreCivic has been a flexible and dependable partner for government for more than 35 years. CoreCivic’s employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good.

Forward-Looking Statements

This press release contains statements as to our beliefs and expectations of the outcome of future events that are “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. These include, but are not limited to, the risks and uncertainties associated with: (i) changes in government policy (including the United States Department of Justice, or DOJ, not renewing contracts as a result of President Biden’s Executive Order on Reforming Our Incarceration System to Eliminate the Use of Privately Operated Criminal Detention Facilities, or the Private Prison EO) (two agencies of the DOJ, the United States Federal Bureau of Prisons and the United States Marshals Service utilize our services), legislation and regulations that affect utilization of the private sector for corrections, detention, and residential reentry services, in general, or our business, in particular, including, but not limited to, the continued utilization of our correctional and detention facilities by the federal government, and the impact of any changes to immigration reform and sentencing laws (our company does not, under longstanding policy, lobby for or against policies or legislation that would determine the basis for, or duration of, an individual’s incarceration or detention); (ii) our ability to obtain and maintain correctional, detention, and residential reentry facility management contracts because of reasons including, but not limited to, sufficient governmental appropriations, contract compliance, negative publicity and effects of inmate disturbances; (iii) changes in the privatization of the corrections and detention industry, the acceptance of our services, the timing of the opening of new facilities and the commencement of new management contracts (including the extent and pace at which new contracts are utilized), as well as our ability to utilize available beds; (iv) general economic and market conditions, including, but not limited to, the impact governmental budgets can have on our contract renewals and renegotiations, per diem rates, and occupancy; (v) fluctuations in our operating results because of, among other things, changes in occupancy levels; competition; contract renegotiations or terminations; inflation and other increases in costs of operations, including a continuing rise in labor costs; fluctuations in interest rates and risks of operations; (vi) the duration of the federal government’s denial of entry at the United States southern border to asylum-seekers and anyone crossing the southern border without proper documentation or authority in an effort to contain the spread of COVID-19; (vii) government and staff responses to staff or residents testing positive for COVID-19 within public and private correctional, detention and reentry facilities, including the facilities we operate; (viii)  restrictions associated with COVID-19 that disrupt the criminal justice system, along with government policies on prosecutions and newly ordered legal restrictions that affect the number of people placed in correctional, detention, and reentry facilities, including those associated with a resurgence of COVID-19; (ix) whether revoking our REIT election, effective January 1, 2021, and our revised capital allocation strategy can be implemented in a cost effective manner that provides the expected benefits, including facilitating our planned debt reduction initiative and planned return of capital to shareholders; (x) our ability to successfully identify and consummate future development and acquisition opportunities and realize projected returns resulting therefrom; (xi) our ability, following our revocation of our REIT election, to identify and initiate service opportunities that were unavailable under the REIT structure; (xii) our ability to have met and maintained qualification for taxation as a REIT for the years we elected REIT status; and (xiii) the availability of debt and equity financing on terms that are favorable to us, or at all. Other factors that could cause operating and financial results to differ are described in the filings we make from time to time with the Securities and Exchange Commission.

CoreCivic takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release or the information contained herein by any third-parties, including, but not limited to, any wire or internet services.


CORECIVIC, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

ASSETS   December 31,
2021
  December 31,
2020
         
Cash and cash equivalents   $ 299,645     $ 113,219  
Restricted cash     11,062       23,549  
Accounts receivable, net of credit loss reserve of $7,931 and $6,103, respectively     282,809       267,705  
Prepaid expenses and other current assets     26,872       33,243  
Assets held for sale     6,996       279,406  
Total current assets     627,384       717,122  
Real estate and related assets:        
Property and equipment, net of accumulated depreciation of $1,657,709 and $1,559,388, respectively     2,283,256       2,350,272  
Other real estate assets     218,915       228,243  
Goodwill     4,844       5,902  
Non-current deferred tax assets           11,113  
Other assets     364,539       396,663  
         
Total assets   $ 3,498,938     $ 3,709,315  
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
         
Accounts payable and accrued expenses   $ 305,592     $ 274,318  
Current portion of long-term debt     35,376       39,087  
Total current liabilities     340,968       313,405  
         
Long-term debt, net     1,492,046       1,747,664  
Deferred revenue     27,551       18,336  
Non-current deferred tax liabilities     88,157        
Other liabilities     177,748       216,468  
         
Total liabilities     2,126,470       2,295,873  
         
Commitments and contingencies        
         
Preferred stock ? $0.01 par value; 50,000 shares authorized; none issued and outstanding at December 31, 2021 and 2020, respectively            
Common stock ? $0.01 par value; 300,000 shares authorized; 120,285 and 119,638 shares issued and outstanding at December 31, 2021 and 2020, respectively     1,203       1,196  
Additional paid-in capital     1,869,955       1,835,494  
Accumulated deficit     (498,690 )     (446,519 )
Total stockholders’ equity     1,372,468       1,390,171  
Non-controlling interest – operating partnership           23,271  
Total equity     1,372,468       1,413,442  
         
Total liabilities and stockholders’ equity   $ 3,498,938     $ 3,709,315  
                 

CORECIVIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

    For the Three Months Ended
December 31,
  For the Year Ended
December 31,
      2021       2020       2021       2020  
                 
REVENUES:                
Safety   $ 432,785     $ 424,318     $ 1,693,968     $ 1,706,232  
Community     25,313       25,320       99,435       105,990  
Properties     14,007       23,802       68,934       93,098  
Other     28       37       279       165  
      472,133       473,477       1,862,616       1,905,485  
                 
EXPENSES:                
Operating                
Safety     309,948       315,127       1,236,938       1,288,938  
Community     20,059       21,158       81,610       88,903  
Properties     2,832       6,857       18,155       28,128  
Other     80       65       362       407  
Total operating expenses     332,919       343,207       1,337,065       1,406,376  
General and administrative     38,412       27,031       135,770       124,338  
Depreciation and amortization     33,951       36,425       134,738       150,861  
Contingent consideration for acquisition of businesses                       620  
Shareholder litigation expense                 54,295        
Asset impairments     2,027       47,570       11,378       60,628  
      407,309       454,233       1,673,246       1,742,823  
                 
OTHER INCOME (EXPENSE):                
Interest expense, net     (23,239 )     (19,572 )     (85,542 )     (83,299 )
Expenses associated with debt repayments and refinancing transactions     (4,112 )     (7,141 )     (56,279 )     (7,141 )
Gain (loss) on sale of real estate assets, net           (17,943 )     38,766       (13,023 )
Other income (expense)     (105 )     (188 )     (212 )     525  
                 
INCOME (LOSS) BEFORE INCOME TAXES     37,368       (25,600 )     86,103       59,724  
                 
Income tax expense     (9,331 )     (1,203 )     (137,999 )     (4,386 )
NET INCOME (LOSS)     28,037       (26,803 )     (51,896 )     55,338  
                 
Net income attributable to non-controlling interest              –                   (1,181 )
                 
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS   $ 28,037     $ (26,803 )   $ (51,896 )   $ 54,157  
                 
                 
BASIC EARNINGS (LOSS) PER SHARE   $  0.23     $ (0.22 )   $  (0.43 )   $ 0.45  
                 
DILUTED EARNINGS (LOSS) PER SHARE   $ 0.23     $ (0.22 )   $ (0.43 )   $ 0.45  
                                 

CORECIVIC, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

CALCULATION OF ADJUSTED NET INCOME AND ADJUSTED DILUTED EPS

  For the Three Months Ended
December 31,
  For the Year Ended
December 31,
    2021       2020       2021       2020
               
Net income (loss) attributable to common stockholders $ 28,037     $ (26,803 )   $ (51,896 )   $ 54,157
Non-controlling interest                     1,181
Diluted net income (loss) attributable to common stockholders $ 28,037     $ (26,803 )   $ (51,896 )   $ 55,338
                             
Special items:                            
Expenses associated with debt repayments and refinancing transactions   4,112       7,141       56,279       7,141
Expenses associated with mergers and acquisitions                     338
Expenses associated with COVID-19         2,792       2,434       13,777
Expenses associated with changes in corporate tax structure         195             5,240
Income taxes associated with change in corporate tax structure and other special tax items               114,249       3,085
Contingent consideration for acquisition of businesses                     620
Loss (gain) on sale of real estate assets, net         17,943       (38,766 )     13,023
Shareholder litigation expense               54,295      
Asset impairments   2,027       47,570       11,378       60,628
Income tax expense (benefit) for special items   (1,533 )           (21,227 )     532
Adjusted net income $ 32,643     $ 48,838     $ 126,746     $ 159,722
Weighted average common shares outstanding – basic   120,285       119,636       120,192       119,559
Effect of dilutive securities:                            
Restricted stock-based awards   933       56       531       28
Non-controlling interest – operating partnership units         1,342       952       1,342
Weighted average shares and assumed conversions – diluted   121,218       121,034       121,675       120,929
Adjusted Earnings Per Diluted Share $ 0.27     $ 0.40     $ 1.04     $ 1.32
                             

CORECIVIC, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

CALCULATION OF FUNDS FROM OPERATIONS AND NORMALIZED FUNDS FROM OPERATIONS

  For the Three Months Ended
December 31,
  For the Year Ended
December 31,
    2021       2020       2021       2020
               
Net income (loss) $ 28,037     $ (26,803 )   $ (51,896 )   $ 55,338
Depreciation and amortization of real estate assets   25,176       27,447       98,738       112,046
Impairment of real estate assets   2,027       4,225       3,335       14,380
Loss (gain) on sale of real estate assets, net         17,943       (38,766 )     13,023
Income tax expense for special items   (506 )           8,785       532
Funds From Operations $ 54,734     $ 22,812     $ 20,196     $ 195,319
                             
Expenses associated with debt repayments and refinancing transactions   4,112       7,141       56,279       7,141
Expenses associated with mergers and acquisitions                     338
Contingent consideration for acquisition of businesses                     620
Expenses associated with COVID-19         2,792       2,434       13,777
Expenses associated with changes in corporate tax structure         195             5,240
Income taxes associated with change in corporate tax structure and other special tax items               114,249       3,085
Shareholder litigation expense               54,295      
Goodwill and other impairments         43,345       8,043       46,248
Income tax benefit for special items   (1,027 )           (30,012 )    
Normalized Funds From Operations $ 57,819     $ 76,285     $ 225,484     $ 271,768
                             
Funds From Operations Per Diluted Share $ 0.45     $ 0.19     $ 0.17     $ 1.62
Normalized Funds From Operations Per Diluted Share $ 0.48     $ 0.63     $ 1.85     $ 2.25
                             

CORECIVIC, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

CALCULATION OF EBITDA AND ADJUSTED EBITDA

  For the Three Months Ended
December 31,
  For the Year Ended
December 31,
    2021     2020       2021       2020
               
Net income (loss) $ 28,037   $ (26,803 )   $ (51,896 )   $ 55,338
Interest expense   25,700     22,216       95,565       93,453
Depreciation and amortization   33,951     36,425       134,738       150,861
Income tax expense   9,331     1,203       137,999       4,386
EBITDA $ 97,019   $ 33,041     $ 316,406     $ 304,038
Expenses associated with debt repayments and refinancing transactions   4,112     7,141       56,279       7,141
Expenses associated with mergers and acquisitions                   338
Expenses associated with COVID-19       2,792       2,434       13,777
Expenses associated with changes in corporate tax structure       195             5,240
Contingent consideration for acquisition of businesses                   620
Loss (gain) on sale of real estate assets, net       17,943       (38,766 )     13,023
Shareholder litigation expense             54,295      
Asset impairments   2,027     47,570       11,378       60,628
Adjusted EBITDA $ 103,158   $ 108,682     $ 402,026     $ 404,805

GUIDANCE — CALCULATION OF FUNDS FROM OPERATIONS & EBITDA

  For the Year Ending
December 31, 2022
  Low End of
Guidance
High End of
Guidance
Net income $ 85,500 $ 102,750
Depreciation and amortization of real estate assets   98,500   99,000
Funds From Operations $ 184,000 $ 201,750
Diluted EPS $ 0.72 $ 0.86
FFO per diluted share $ 1.55 $ 1.70
     
Net income $ 85,500 $ 102,750
Interest expense   97,500   96,500
Depreciation and amortization   134,750   134,750
Income tax expense   37,000   36,000
EBITDA $ 354,750 $ 370,000

NOTE TO SUPPLEMENTAL FINANCIAL INFORMATION

Adjusted Net Income, EBITDA, Adjusted EBITDA, FFO, and Normalized FFO, and, where appropriate, their corresponding per share metrics are non-GAAP financial measures. The Company believes that these measures are important operating measures that supplement discussion and analysis of the Company’s results of operations and are used to review and assess operating performance of the Company and its properties and their management teams. The Company believes that it is useful to provide investors, lenders and security analysts disclosures of its results of operations on the same basis that is used by management.   FFO, in particular, is a widely accepted non-GAAP supplemental measure of performance of real estate companies, grounded in the standards for FFO established by the National Association of Real Estate Investment Trusts (NAREIT).

NAREIT defines FFO as net income computed in accordance with GAAP, excluding gains (or losses) from sales of property and extraordinary items, plus depreciation and amortization of real estate and impairment of depreciable real estate and after adjustments for unconsolidated partnerships and joint ventures calculated to reflect funds from operations on the same basis.   EBITDA, Adjusted EBITDA, and Normalized FFO are useful as supplemental measures of performance of the Company’s properties because such measures do not take into account depreciation and amortization, or with respect to EBITDA, the impact of the Company’s tax provisions and financing strategies. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), this accounting presentation assumes that the value of real estate assets diminishes at a level rate over time.   Because of the unique structure, design and use of the Company’s properties, management believes that assessing performance of the Company’s properties without the impact of depreciation or amortization is useful. The Company may make adjustments to FFO from time to time for certain other income and expenses that it considers non-recurring, infrequent or unusual, even though such items may require cash settlement, because such items do not reflect a necessary or ordinary component of the ongoing operations of the Company.   Normalized FFO excludes the effects of such items. The Company calculates Adjusted Net Income by adding to GAAP Net Income expenses associated with the Company’s debt repayments and refinancing transactions, and certain impairments and other charges that the Company believes are unusual or non-recurring to provide an alternative measure of comparing operating performance for the periods presented.

Other companies may calculate Adjusted Net Income, EBITDA, Adjusted EBITDA, FFO, and Normalized FFO differently than the Company does, or adjust for other items, and therefore comparability may be limited.   Adjusted Net Income, EBITDA, Adjusted EBITDA, FFO, and Normalized FFO and, where appropriate, their corresponding per share measures are not measures of performance under GAAP, and should not be considered as an alternative to cash flows from operating activities, a measure of liquidity or an alternative to net income as indicators of the Company’s operating performance or any other measure of performance derived in accordance with GAAP.   This data should be read in conjunction with the Company’s consolidated financial statements and related notes included in its filings with the Securities and Exchange Commission.

Contact:    Investors: Cameron Hopewell – Managing Director, Investor Relations – (615) 263-3024
      Financial Media: David Gutierrez, Dresner Corporate Services – (312) 780-7204

Bowlero Corp. Announces Strong Financial Results For The Second Quarter Of Fiscal Year 2022



Bowlero Corp. Announces Strong Financial Results For The Second Quarter Of Fiscal Year 2022

Research, News, and Market Data on Bowlero

 

  • Significant growth in Revenue, totaling over $200 million, grew 177.3% year over year and 11% relative to pre-pandemic performance; 1.6% on a same-store basis vs. pre-pandemic levels.

  • Net Loss for the Quarter of $34.5 million was driven primarily by expenses related to the successful de-SPAC transaction, which include $29.1 million in transactional expenses and $42.2 million in share based compensation, partially offset by $22.5 million in income related to the change in the fair value of earnouts and warrants. Net Income for the quarter, adjusted for these items was $14.4 million vs. a net loss of $49.1 million in the prior year. 1

  • Adjusted EBITDA grew to $66.8 million, up 26.2% relative to pre-pandemic performance and $70.5 million vs. prior fiscal year. 1

  • Trailing fifty-two week Net Loss was $55.4 million. Trailing fifty-two week Adjusted EBITDA of $195.3 million exceeded pre-pandemic levels by 12.3%. 1

RICHMOND, Va., Feb. 09, 2022 (GLOBE NEWSWIRE) — Bowlero Corp. (NYSE: BOWL) (“Bowlero” or the “Company”), the world’s largest owner and operator of bowling centers, today provided financial results for the 2022 fiscal year second quarter, which ended on December 26, 2021. Bowlero announced that it grew revenue in the quarter to over $200 million, driven by strong growth in walk in retail revenue. Total revenue grew by 11% compared to pre-pandemic levels and by 177.3% on a year-over-year basis. Same-store sales rose by 1.6% relative to pre-pandemic levels.

“As we enter the new calendar year, we are excited to see our bowling centers filled with guests and we look forward to continuing to provide the best-in-class bowling experience that they have to come to expect from Bowlero”, said Tom Shannon, Founder and Chief Executive Officer.

Second Quarter Financial Summary

  • Significant growth in Revenue, totaling over $200 million, up 11% relative to pre-pandemic performance and 177.3% on a year-over-year basis; 1.6% on a same-store basis vs. pre-pandemic levels despite headwinds of Omicron, and Halloween and Christmas falling on weekends.
  • Net Loss for the Quarter of $34.5 million was driven primarily by expenses related to the successful de-SPAC transaction, which include $29.1 million in transactional expenses and $42.2 million in share based compensation, partially offset by $22.5 million in income related to the change in the fair value of earnouts and warrants. Net Income for the quarter, adjusted for these items was $14.4 million vs. a net loss of $49.1 million in the prior year.1
  • Adjusted EBITDA grew to $66.8 million, up 26.2% relative to pre-pandemic performance and $70.5 million vs. prior fiscal year.1
  • Trailing fifty-two week Net Loss was $55.4 million. Trailing fifty-two week Adjusted EBITDA of $195.3 million exceeded pre-pandemic levels by 12.3%.1
  • Cash generated from Operations was $27.7 million.

Bowlero Corp. also grew its bowling center portfolio during the quarter by adding five new bowling centers in the United States – consisting of three acquisitions of centers in Spring Hill, FL, Port St. Lucie, FL, and Vacaville, CA, along with the opening of two newly constructed centers in Oxnard, CA and Tysons Corner, VA.

“We are continuing to see significant growth, both organically, through same-store improvements, and inorganically, through unit additions,” said Brett Parker, President and CFO of Bowlero Corp. “The revenue growth in the second quarter came despite the recent COVID wave disrupting what is typically a corporate event-heavy quarter. Additionally, both Halloween and Christmas being celebrated on Saturdays negatively impacted our revenue in the quarter. Nevertheless, we still had one of our highest grossing quarters of all time, produced powerful growth in Revenue and Adjusted EBITDA, and generated nearly $28 million in cash from operations.”

Total Bowling Center Revenue 2 Performance Trend

Chart for Bowlero Corporation Revenue Performance Summary vs. Pre-COVID Performance:
https://www.globenewswire.com/NewsRoom/AttachmentNg/6c174dbe-cd68-4a36-bc8f-d4dfcb649562

Investor Webcast Information
Listeners may access an investor webcast hosted by Bowlero. The webcast and results presentation will be accessible today at 5:30 PM ET in the Events & Presentations section of the Bowlero Investor Relations website at https://ir.bowlerocorp.com/overview/default.aspx

About Bowlero Corp.
Bowlero Corp. is the worldwide leader in bowling entertainment. With more than 300 bowling centers across North America, Bowlero Corp. serves more than 26 million guests each year through a family of brands that includes Bowlero, Bowlmor Lanes, and AMF. Bowlero Corp. is also home to the Professional Bowlers Association, which it acquired in 2019 and which boasts thousands of members and millions of fans across the globe. For more information on Bowlero Corp., please visit BowleroCorp.com.

Forward Looking Statements

Some of the statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are generally identified by the use of words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology and include preliminary results. These forward-looking statements reflect our views with respect to future events as of the date of this release and are based on our management’s current expectations, estimates, forecasts, projections, assumptions, beliefs and information. Although management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. All such forward-looking statements are subject to risks and uncertainties, many of which are outside of our control, and could cause future events or results to be materially different from those stated or implied in this document. It is not possible to predict or identify all such risks. These risks include, but are not limited to: the impact of COVID-19 or other adverse public health developments on our business; our ability to grow and manage growth profitably, maintain relationships with customers, compete within our industry and retain our key employees; changes in consumer preferences and buying patterns; the possibility that we may be adversely affected by other economic, business, and/or competitive factors; the risk that the market for our entertainment offerings may not develop on the timeframe or in the manner that we currently anticipate; general economic conditions and uncertainties affecting markets in which we operate and economic volatility that could adversely impact our business, including the COVID-19 pandemic and other factors described under the section titled “Risk Factors” in the registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “SEC”) by the Company, as well as other filings that the Company will make, or has made, with the SEC, such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in other filings. We expressly disclaim any obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law.

GAAP Financial Statements

Bowlero Corp.
Consolidated Balance Sheets
(Amounts in thousands, except share and per share amounts)
(UNAUDITED)
         
    December 26, 2021   June 27, 2021
         
Assets        
Current assets:        
Cash and cash equivalents $ 115,659   $ 187,093  
Accounts and notes receivable, net of allowance for doubtful        
accounts of $200 and $204, respectively   4,458     3,300  
Inventories, net   10,397     8,310  
Prepaid expenses and other current assets   12,088     8,056  
Assets held-for-sale   14,281     686  
Total current assets   156,883     207,445  
         
Property and equipment, net   514,991     415,661  
Internal use software, net   9,866     9,062  
Property and equipment under capital leases, net   280,324     284,077  
Intangible assets, net   96,517     96,057  
Goodwill   739,011     726,156  
Investment in joint venture   1,168     1,230  
Other assets   42,450     42,550  
Total assets $ 1,841,210   $ 1,782,238  
         
Liabilities, Mezzanine Equity and Stockholders’ Deficit        
Current liabilities:        
Accounts payable $ 37,974   $ 29,489  
Accrued expenses   69,690     63,650  
Current maturities of long-term debt   4,983     5,058  
Other current liabilities   8,185     9,176  
Total current liabilities   120,832     107,373  
         
Long-term debt, net   869,606     870,528  
Long-term obligations under capital leases   386,989     374,598  
Earnout liability   158,572      
Warrant liability   22,495      
Other long-term liabilities   80,857     87,749  
Deferred income tax liabilities   14,234     11,867  
Total liabilities   1,653,585     1,452,115  
         
Mezzanine Equity        
Series A preferred stock – Old Bowlero       141,162  
         
Series A preferred stock   200,000      
         
Redeemable Class A common stock – Old Bowlero       464,827  
         
Stockholders’ deficit:        
Class A common stock   11     10  
Class B common stock   6      
Additional paid-in capital   294,828      
Accumulated deficit   (301,807 )   (266,472 )
Accumulated other comprehensive loss   (5,413 )   (9,404 )
Total stockholders’ deficit   (12,375 )   (275,866 )
         
    Total liabilities, mezzanine equity and stockholders’ deficit $ 1,841,210   $ 1,782,238  
         

 

  Bowlero Corp.
  Consolidated Statements of Operations
  (Amounts in thousands, except share and per share amounts)
  (UNAUDITED)
               
      Three Months Ended
      December 26, 2021   December 27, 2020   December 29, 2019
               
  Revenues $ 205,190     73,988     184,842  
               
  Costs of revenues   141,383     86,045     132,843  
               
  Gross profit (loss)   63,807     (12,057 )   51,999  
               
  Operating (income) expenses:            
  Selling, general and administrative expenses 93,283     16,481     25,162  
  Loss (gain) on sale or disposal of assets   (124 )   (142 )   219  
  Income from joint venture   (79 )   (40 )   (60 )
  Management fee income   (109 )   (13 )   (166 )
  Other expense (income)   3,520     (1,565 )   438  
  Total operating expense, net   96,491     14,721     25,593  
               
  Operating (loss) income   (32,684 )   (26,778 )   26,406  
               
  Nonoperating (income) expenses:            
  Interest expense, net   23,880     22,253     19,805  
  Change in fair value of earnout shares   (22,542 )        
  Change in fair value of warrant liability   70          
  Total nonoperating expense, net   1,408     22,253     19,805  
               
  Loss before income tax expense (benefit) (34,092 )   (49,031 )   6,601  
               
  Income tax expense (benefit)   362     106     153  
               
  Net loss $ (34,454 ) $ (49,137 )   6,448  
               

 

Bowlero Corp.
Consolidated Statements of Cash Flows
(Amounts in thousands)
(UNAUDITED)
    Six Months Ended
    December 26, 2021   December 27, 2020
         
Net cash provided (used) by operating activities $ 59,285   $ (11,599 )
Net cash used in investing activities   (160,848 )   (18,702 )
Net cash provided by financing activities   30,213     38,883  
Effect of exchange rate changes on cash   (84 )   (81 )
Net (decrease) increase in cash and equivalents   (71,434 )   8,501  
         
Cash and cash equivalents at beginning of period   187,093     140,705  
         
Cash and cash equivalents at end of period   115,659     149,206  
         


GAAP to non-GAAP Reconciliations

  ADJUSTED EBITDA RECONCILIATION
  Thirteen week Net (loss) income and Adjusted EBITDA
(in thousands) December 26, 2021 December 27, 2020 December 29, 2019
Net (loss) income   (34,454 )     (49,137 )     6,448  
Adjustments:      
Interest expense   23,880     22,253     19,805  
Income tax expense (benefit)   362     106     153  
Depreciation and amortization   25,660     22,538     21,772  
Share-based compensation   42,555     696     852  
Closed center EBITDA [1]   398     904     1,885  
Foreign currency exchange (gain) loss   86     (195)     (236)  
Asset disposition loss (gain)   (123)     (142)     219  
Transactional and other advisory costs [2]   29,149     731     1,087  
Charges attributed to new initiatives [3]   65     116     230  
Extraordinary unusual non-recurring losses [4]   1,662     (1,647)     673  
Changes in the value of earnouts and warrants   (22,472)     0     0  
ADJUSTED EBITDA   $ 66,768     ($3,777 )     $52,888  
       
SG&A Expense   $20,219     $13,241     $19,617  
Media & Other Income   ($4,228)     ($305)     ($316)  
CENTER EBITDA   $82,759     $9,159     $72,190  
Rent Expense   $15,730     $13,267     $14,239  
CENTER EBITDAR   $98,489     $22,426     $86,429  

1 The closed center adjustment is to remove EBITDA for closed centers. Closed centers are those centers that are closed for a variety of reasons, including permanent closure, newly acquired or built centers prior to opening, centers closed for renovation or rebranding and conversion. Closed centers do not include centers closed in compliance with local, state and federal government restrictions due to COVID-19. If a center is not open on the last day of the reporting period, it will be considered closed for that reporting period. If the center is closed on the first day of the reporting period for permanent closure, the center will be considered closed for that reporting period.

2 The adjustment for transaction costs and other advisory costs is to remove charges incurred in connection with any transaction, including mergers, acquisitions, refinancing, amendment or modification to indebtedness, dispositions and costs in connection with an initial public offering, in each case, regardless of whether consummated.

3 The adjustment for charges is to remove charges attributed to new initiatives include charges with the undertaking and/or implementation of new initiatives, business optimization activities, cost savings initiatives, cost rationalization programs, operating expense reductions and/or synergies and/or similar initiatives and/or programs (including in connection with any integration, restructuring or transition, any reconstruction, decommissioning, recommissioning or reconfiguration of fixed assets for alternative uses, any office or facility opening and/or pre-opening), including any inventory optimization program and/or any curtailment, any business optimization charge, any restructuring charge (including any charges relating to any tax restructuring), any charge relating to the closure or consolidation of any office or facility (including but not limited to rent termination costs, moving costs and legal costs), any systems implementation charge, any severance charge, any one time compensation charge, any charge relating to entry into a new market, any charge relating to any strategic initiative or contract, any charge relating to any entry into new markets and contracts, any lease run-off charge, any charge associated with improvements to information technology (IT) or accounting functions, losses related to temporary decreases in work volume and expenses related to maintaining underutilized personnel, any charge relating to a new contract, any consulting charge and/or any corporate development charge; provided, that, in the case of any such charge, the results of any such action relating to such charge are projected by in good faith to be achieved within 24 months of the undertaking.

4 The adjustment for extraordinary unusual non-recurring gains or losses is to remove extraordinary gains and losses, which include any gain or charge from any extraordinary item as determined in good faith by the Company and/or any non-recurring or unusual item as determined in good faith by the Company and/or any charge associated with and/or payment of any legal settlement, fine, judgment or order.

Chart for Trailing Fifty-Two Week Net Loss & Adjusted EBITDA is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d77b5c05-9244-4376-b674-a51da0db1868

 

TRAILING 52-WEEK ADJUSTED EBITDA RECONCILIATION
Fifty-two week Net (loss) income and Adjusted EBITDA
(in thousands) December 29, 2019 December 27, 2020 March 28, 2021 June 27, 2021 September 26, 2021 December 26, 2021
Net (loss) income   (1,841 )     (167,530 )     (197,748 )     (126,461 )     (70,125 )     (55,442 )  
Adjustments:            
Interest expense   69,903     84,598     86,352     88,857     90,612     92,239  
Income tax expense (benefit)   1,803     8,187     7,927     (1,035)     (7,403)     (7,147)  
Depreciation and amortization   89,264     91,349     91,411     91,851     92,241     95,363  
Share-based compensation   3,406     3,255     3,226     3,164     3,116     44,975  
Closed center EBITDA [1]   (400)     3,482     3,259     4,039     3,880     3,374  
Foreign currency exchange (gain) loss   (225)     59     (146)     (188)     (155)     126  
Asset disposition loss (gain)   5,247     920     613     (46)     (77)     (58)  
Transactional and other advisory costs [2]   3,041     5,208     5,573     10,737     12,056     40,474  
Charges attributed to new initiatives [3]   1,020     543     500     531     540     489  
Extraordinary unusual non-recurring losses [4]   2,680     (2,501)     360     1,670     65     3,374  
Changes in the value of earnouts and warrants   0     0     0     0     0     (22,472)  
ADJUSTED EBITDA   $ 173,898     $ 27,570     $ 1,327     $ 73,119     $ 124,750     $ 195,295  

1 The closed center adjustment is to remove EBITDA for closed centers. Closed centers are those centers that are closed for a variety of reasons, including permanent closure, newly acquired or built centers prior to opening, centers closed for renovation or rebranding and conversion. Closed centers do not include centers closed in compliance with local, state and federal government restrictions due to COVID-19. If a center is not open on the last day of the reporting period, it will be considered closed for that reporting period. If the center is closed on the first day of the reporting period for permanent closure, the center will be considered closed for that reporting period.

2 The adjustment for transaction costs and other advisory costs is to remove charges incurred in connection with any transaction, including mergers, acquisitions, refinancing, amendment or modification to indebtedness, dispositions and costs in connection with an initial public offering, in each case, regardless of whether consummated.

3 The adjustment for charges is to remove charges attributed to new initiatives include charges with the undertaking and/or implementation of new initiatives, business optimization activities, cost savings initiatives, cost rationalization programs, operating expense reductions and/or synergies and/or similar initiatives and/or programs (including in connection with any integration, restructuring or transition, any reconstruction, decommissioning, recommissioning or reconfiguration of fixed assets for alternative uses, any office or facility opening and/or pre-opening), including any inventory optimization program and/or any curtailment, any business optimization charge, any restructuring charge (including any charges relating to any tax restructuring), any charge relating to the closure or consolidation of any office or facility (including but not limited to rent termination costs, moving costs and legal costs), any systems implementation charge, any severance charge, any one time compensation charge, any charge relating to entry into a new market, any charge relating to any strategic initiative or contract, any charge relating to any entry into new markets and contracts, any lease run-off charge, any charge associated with improvements to information technology (IT) or accounting functions, losses related to temporary decreases in work volume and expenses related to maintaining underutilized personnel, any charge relating to a new contract, any consulting charge and/or any corporate development charge; provided, that, in the case of any such charge, the results of any such action relating to such charge are projected by in good faith to be achieved within 24 months of the undertaking.

4 The adjustment for extraordinary unusual non-recurring gains or losses is to remove extraordinary gains and losses, which include any gain or charge from any extraordinary item as determined in good faith by the Company and/or any non-recurring or unusual item as determined in good faith by the Company and/or any charge associated with and/or payment of any legal settlement, fine, judgment or order.

 

NORMALIZED NET INCOME RECONCILIATION
Thirteen week Net (loss) income
(in thousands) December 26, 2021
Net (loss) income ($ 34,454 )  
   
Share-based compensation – de-SPAC $42,212  
Change in FV of earnouts and warrants ($22,472)  
Transactional and other advisory costs – de-SPAC $29,149  
   
Normalized Net Income $ 14,435  
   

Non-GAAP Financial Measures

To provide investors with information in addition to our results as determined under Generally Accepted Accounting Principles (“GAAP”), we disclose net income, normalized for extraordinary and non-recurring items related to the de-SPAC transaction, Adjusted EBITDA and trailing fifty-two week Adjusted EBITDA as “non-GAAP measures” which management believes provide useful information to investors because each measure assists both investors and management in analyzing and benchmarking the performance and value of our business. Accordingly, management believes that these measurements are useful for comparing general operating performance from period to period, and management relies on these measures for planning and forecasting of future periods. Additionally, these measures allow management to compare our results with those of other companies that have different financing and capital structures. These measures are not financial measures calculated in accordance with GAAP and should not be considered as a substitute for revenue, net income, net cash provided (used) by operating activities or any other operating performance or liquidity measure calculated in accordance with GAAP, and may not be comparable to a similarly titled measure reported by other companies.

Net income normalized for extraordinary and non-recurring items related to the de-SPAC transaction represents Net income (loss) before share-based compensation issued in connection with the Company’s de-SPAC transaction and transaction and other advisory costs related to the de-SPAC transaction. Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“Adjusted EBITDA”) represents Net income (loss) before Interest, Income Taxes, Depreciation and Amortization, Share-based Compensation, EBITDA from Closed Centers, Foreign Currency Exchange Loss (Gain), Asset Disposition Loss (Gain), Transactional and other advisory costs, Charges attributed to new initiatives, Extraordinary unusual non-recurring gains or losses and Changes in the value of earnouts and warrants. Trailing fifty-two week Adjusted EBITDA represents Adjusted EBITDA over the most recent fifty-two week period.

The Company considers net income normalized for extraordinary and non-recurring items related to the de-SPAC transaction as an important financial measure because it provides an indicator of performance that is not affected by fluctuations in certain costs or other items. However, this measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that it does not reflect every cash expenditure and is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows.

The Company considers Adjusted EBITDA as an important financial measure because it provides a financial measure of the quality of the Company’s earnings. Other companies may calculate Adjusted EBITDA differently than we do, which might limit its usefulness as a comparative measure. Adjusted EBITDA is used by management in addition to and in conjunction with the results presented in accordance with GAAP. Additionally, we believe trailing fifty-two week Adjusted EBITDA provides the current run-rate for trending purposes, rather than annualizing the respective quarters, as the Company’s business is seasonal, with the second and third fiscal quarters being higher than the first and last quarters.

We have presented Adjusted EBITDA solely as a supplemental disclosure because we believe it allows for a more complete analysis of results of operations and assists investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance, such as Interest, Income Taxes, Depreciation and Amortization, Share-based Compensation, EBITDA from Closed Centers, Foreign Currency Exchange Loss (Gain), Asset Disposition Loss (Gain), Transactional and other advisory costs, Charges attributed to new initiatives, Extraordinary unusual non-recurring gains or losses and Changes in the value of earnouts and warrants.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that Adjusted EBITDA and trailing fifty-two week Adjusted EBITDA:

  • do not reflect every expenditure, future requirements for capital expenditures or contractual commitments;
  • do not reflect changes in our working capital needs;
  • do not reflect the interest expense, or the amounts necessary to service interest or principal payments, on our outstanding debt;
  • do not reflect income tax (benefit) expense, and because the payment of taxes is part of our operations, tax expense is a necessary element of our costs and ability to operate;
  • do not reflect non-cash equity compensation, which will remain a key element of our overall equity based compensation package; and
  • do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations.

Contacts:

For Media:
Jillian Laufer
JLaufer@BowleroCorp.com

For Investors:
ICR, Inc.
Ryan Lawrence
Ryan.Lawrence@icrinc.com

Ashley DeSimone
Ashley.desimone@icrinc.com

1 “GAAP” stands for Generally Accepted Accounting Principles in the U.S. Please see the sections of this document titled “GAAP Financial Statements” and “GAAP to non-GAAP Reconciliations” for more information on the Company’s GAAP and non-GAAP measures. Certain figures in the tables throughout this document may not foot due to rounding.
2 Total Bowling Center Revenue excludes closed bowling center activity and media revenue, which is also a component of our bowling operations. For weeks between 9/5/21 and 12/26/21, the percentages above are calculated by comparing each week to the comparable week in 2019. For weeks after 12/26/21, the percentages above are calculated by comparing each week to the comparable week in 2020. Data for all weeks following the close of the quarter ended on 12/26/21 are preliminary.

Source: Bowlero Corp

Release – Bowlero Corp. Announces Strong Financial Results For The Second Quarter Of Fiscal Year 2022



Bowlero Corp. Announces Strong Financial Results For The Second Quarter Of Fiscal Year 2022

Research, News, and Market Data on Bowlero

 

  • Significant growth in Revenue, totaling over $200 million, grew 177.3% year over year and 11% relative to pre-pandemic performance; 1.6% on a same-store basis vs. pre-pandemic levels.

  • Net Loss for the Quarter of $34.5 million was driven primarily by expenses related to the successful de-SPAC transaction, which include $29.1 million in transactional expenses and $42.2 million in share based compensation, partially offset by $22.5 million in income related to the change in the fair value of earnouts and warrants. Net Income for the quarter, adjusted for these items was $14.4 million vs. a net loss of $49.1 million in the prior year. 1

  • Adjusted EBITDA grew to $66.8 million, up 26.2% relative to pre-pandemic performance and $70.5 million vs. prior fiscal year. 1

  • Trailing fifty-two week Net Loss was $55.4 million. Trailing fifty-two week Adjusted EBITDA of $195.3 million exceeded pre-pandemic levels by 12.3%. 1

RICHMOND, Va., Feb. 09, 2022 (GLOBE NEWSWIRE) — Bowlero Corp. (NYSE: BOWL) (“Bowlero” or the “Company”), the world’s largest owner and operator of bowling centers, today provided financial results for the 2022 fiscal year second quarter, which ended on December 26, 2021. Bowlero announced that it grew revenue in the quarter to over $200 million, driven by strong growth in walk in retail revenue. Total revenue grew by 11% compared to pre-pandemic levels and by 177.3% on a year-over-year basis. Same-store sales rose by 1.6% relative to pre-pandemic levels.

“As we enter the new calendar year, we are excited to see our bowling centers filled with guests and we look forward to continuing to provide the best-in-class bowling experience that they have to come to expect from Bowlero”, said Tom Shannon, Founder and Chief Executive Officer.

Second Quarter Financial Summary

  • Significant growth in Revenue, totaling over $200 million, up 11% relative to pre-pandemic performance and 177.3% on a year-over-year basis; 1.6% on a same-store basis vs. pre-pandemic levels despite headwinds of Omicron, and Halloween and Christmas falling on weekends.
  • Net Loss for the Quarter of $34.5 million was driven primarily by expenses related to the successful de-SPAC transaction, which include $29.1 million in transactional expenses and $42.2 million in share based compensation, partially offset by $22.5 million in income related to the change in the fair value of earnouts and warrants. Net Income for the quarter, adjusted for these items was $14.4 million vs. a net loss of $49.1 million in the prior year.1
  • Adjusted EBITDA grew to $66.8 million, up 26.2% relative to pre-pandemic performance and $70.5 million vs. prior fiscal year.1
  • Trailing fifty-two week Net Loss was $55.4 million. Trailing fifty-two week Adjusted EBITDA of $195.3 million exceeded pre-pandemic levels by 12.3%.1
  • Cash generated from Operations was $27.7 million.

Bowlero Corp. also grew its bowling center portfolio during the quarter by adding five new bowling centers in the United States – consisting of three acquisitions of centers in Spring Hill, FL, Port St. Lucie, FL, and Vacaville, CA, along with the opening of two newly constructed centers in Oxnard, CA and Tysons Corner, VA.

“We are continuing to see significant growth, both organically, through same-store improvements, and inorganically, through unit additions,” said Brett Parker, President and CFO of Bowlero Corp. “The revenue growth in the second quarter came despite the recent COVID wave disrupting what is typically a corporate event-heavy quarter. Additionally, both Halloween and Christmas being celebrated on Saturdays negatively impacted our revenue in the quarter. Nevertheless, we still had one of our highest grossing quarters of all time, produced powerful growth in Revenue and Adjusted EBITDA, and generated nearly $28 million in cash from operations.”

Total Bowling Center Revenue 2 Performance Trend

Chart for Bowlero Corporation Revenue Performance Summary vs. Pre-COVID Performance:
https://www.globenewswire.com/NewsRoom/AttachmentNg/6c174dbe-cd68-4a36-bc8f-d4dfcb649562

Investor Webcast Information
Listeners may access an investor webcast hosted by Bowlero. The webcast and results presentation will be accessible today at 5:30 PM ET in the Events & Presentations section of the Bowlero Investor Relations website at https://ir.bowlerocorp.com/overview/default.aspx

About Bowlero Corp.
Bowlero Corp. is the worldwide leader in bowling entertainment. With more than 300 bowling centers across North America, Bowlero Corp. serves more than 26 million guests each year through a family of brands that includes Bowlero, Bowlmor Lanes, and AMF. Bowlero Corp. is also home to the Professional Bowlers Association, which it acquired in 2019 and which boasts thousands of members and millions of fans across the globe. For more information on Bowlero Corp., please visit BowleroCorp.com.

Forward Looking Statements

Some of the statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are generally identified by the use of words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology and include preliminary results. These forward-looking statements reflect our views with respect to future events as of the date of this release and are based on our management’s current expectations, estimates, forecasts, projections, assumptions, beliefs and information. Although management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. All such forward-looking statements are subject to risks and uncertainties, many of which are outside of our control, and could cause future events or results to be materially different from those stated or implied in this document. It is not possible to predict or identify all such risks. These risks include, but are not limited to: the impact of COVID-19 or other adverse public health developments on our business; our ability to grow and manage growth profitably, maintain relationships with customers, compete within our industry and retain our key employees; changes in consumer preferences and buying patterns; the possibility that we may be adversely affected by other economic, business, and/or competitive factors; the risk that the market for our entertainment offerings may not develop on the timeframe or in the manner that we currently anticipate; general economic conditions and uncertainties affecting markets in which we operate and economic volatility that could adversely impact our business, including the COVID-19 pandemic and other factors described under the section titled “Risk Factors” in the registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “SEC”) by the Company, as well as other filings that the Company will make, or has made, with the SEC, such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in other filings. We expressly disclaim any obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law.

GAAP Financial Statements

Bowlero Corp.
Consolidated Balance Sheets
(Amounts in thousands, except share and per share amounts)
(UNAUDITED)
         
    December 26, 2021   June 27, 2021
         
Assets        
Current assets:        
Cash and cash equivalents $ 115,659   $ 187,093  
Accounts and notes receivable, net of allowance for doubtful        
accounts of $200 and $204, respectively   4,458     3,300  
Inventories, net   10,397     8,310  
Prepaid expenses and other current assets   12,088     8,056  
Assets held-for-sale   14,281     686  
Total current assets   156,883     207,445  
         
Property and equipment, net   514,991     415,661  
Internal use software, net   9,866     9,062  
Property and equipment under capital leases, net   280,324     284,077  
Intangible assets, net   96,517     96,057  
Goodwill   739,011     726,156  
Investment in joint venture   1,168     1,230  
Other assets   42,450     42,550  
Total assets $ 1,841,210   $ 1,782,238  
         
Liabilities, Mezzanine Equity and Stockholders’ Deficit        
Current liabilities:        
Accounts payable $ 37,974   $ 29,489  
Accrued expenses   69,690     63,650  
Current maturities of long-term debt   4,983     5,058  
Other current liabilities   8,185     9,176  
Total current liabilities   120,832     107,373  
         
Long-term debt, net   869,606     870,528  
Long-term obligations under capital leases   386,989     374,598  
Earnout liability   158,572      
Warrant liability   22,495      
Other long-term liabilities   80,857     87,749  
Deferred income tax liabilities   14,234     11,867  
Total liabilities   1,653,585     1,452,115  
         
Mezzanine Equity        
Series A preferred stock – Old Bowlero       141,162  
         
Series A preferred stock   200,000      
         
Redeemable Class A common stock – Old Bowlero       464,827  
         
Stockholders’ deficit:        
Class A common stock   11     10  
Class B common stock   6      
Additional paid-in capital   294,828      
Accumulated deficit   (301,807 )   (266,472 )
Accumulated other comprehensive loss   (5,413 )   (9,404 )
Total stockholders’ deficit   (12,375 )   (275,866 )
         
    Total liabilities, mezzanine equity and stockholders’ deficit $ 1,841,210   $ 1,782,238  
         

 

  Bowlero Corp.
  Consolidated Statements of Operations
  (Amounts in thousands, except share and per share amounts)
  (UNAUDITED)
               
      Three Months Ended
      December 26, 2021   December 27, 2020   December 29, 2019
               
  Revenues $ 205,190     73,988     184,842  
               
  Costs of revenues   141,383     86,045     132,843  
               
  Gross profit (loss)   63,807     (12,057 )   51,999  
               
  Operating (income) expenses:            
  Selling, general and administrative expenses 93,283     16,481     25,162  
  Loss (gain) on sale or disposal of assets   (124 )   (142 )   219  
  Income from joint venture   (79 )   (40 )   (60 )
  Management fee income   (109 )   (13 )   (166 )
  Other expense (income)   3,520     (1,565 )   438  
  Total operating expense, net   96,491     14,721     25,593  
               
  Operating (loss) income   (32,684 )   (26,778 )   26,406  
               
  Nonoperating (income) expenses:            
  Interest expense, net   23,880     22,253     19,805  
  Change in fair value of earnout shares   (22,542 )        
  Change in fair value of warrant liability   70          
  Total nonoperating expense, net   1,408     22,253     19,805  
               
  Loss before income tax expense (benefit) (34,092 )   (49,031 )   6,601  
               
  Income tax expense (benefit)   362     106     153  
               
  Net loss $ (34,454 ) $ (49,137 )   6,448  
               

 

Bowlero Corp.
Consolidated Statements of Cash Flows
(Amounts in thousands)
(UNAUDITED)
    Six Months Ended
    December 26, 2021   December 27, 2020
         
Net cash provided (used) by operating activities $ 59,285   $ (11,599 )
Net cash used in investing activities   (160,848 )   (18,702 )
Net cash provided by financing activities   30,213     38,883  
Effect of exchange rate changes on cash   (84 )   (81 )
Net (decrease) increase in cash and equivalents   (71,434 )   8,501  
         
Cash and cash equivalents at beginning of period   187,093     140,705  
         
Cash and cash equivalents at end of period   115,659     149,206  
         


GAAP to non-GAAP Reconciliations

  ADJUSTED EBITDA RECONCILIATION
  Thirteen week Net (loss) income and Adjusted EBITDA
(in thousands) December 26, 2021 December 27, 2020 December 29, 2019
Net (loss) income   (34,454 )     (49,137 )     6,448  
Adjustments:      
Interest expense   23,880     22,253     19,805  
Income tax expense (benefit)   362     106     153  
Depreciation and amortization   25,660     22,538     21,772  
Share-based compensation   42,555     696     852  
Closed center EBITDA [1]   398     904     1,885  
Foreign currency exchange (gain) loss   86     (195)     (236)  
Asset disposition loss (gain)   (123)     (142)     219  
Transactional and other advisory costs [2]   29,149     731     1,087  
Charges attributed to new initiatives [3]   65     116     230  
Extraordinary unusual non-recurring losses [4]   1,662     (1,647)     673  
Changes in the value of earnouts and warrants   (22,472)     0     0  
ADJUSTED EBITDA   $ 66,768     ($3,777 )     $52,888  
       
SG&A Expense   $20,219     $13,241     $19,617  
Media & Other Income   ($4,228)     ($305)     ($316)  
CENTER EBITDA   $82,759     $9,159     $72,190  
Rent Expense   $15,730     $13,267     $14,239  
CENTER EBITDAR   $98,489     $22,426     $86,429  

1 The closed center adjustment is to remove EBITDA for closed centers. Closed centers are those centers that are closed for a variety of reasons, including permanent closure, newly acquired or built centers prior to opening, centers closed for renovation or rebranding and conversion. Closed centers do not include centers closed in compliance with local, state and federal government restrictions due to COVID-19. If a center is not open on the last day of the reporting period, it will be considered closed for that reporting period. If the center is closed on the first day of the reporting period for permanent closure, the center will be considered closed for that reporting period.

2 The adjustment for transaction costs and other advisory costs is to remove charges incurred in connection with any transaction, including mergers, acquisitions, refinancing, amendment or modification to indebtedness, dispositions and costs in connection with an initial public offering, in each case, regardless of whether consummated.

3 The adjustment for charges is to remove charges attributed to new initiatives include charges with the undertaking and/or implementation of new initiatives, business optimization activities, cost savings initiatives, cost rationalization programs, operating expense reductions and/or synergies and/or similar initiatives and/or programs (including in connection with any integration, restructuring or transition, any reconstruction, decommissioning, recommissioning or reconfiguration of fixed assets for alternative uses, any office or facility opening and/or pre-opening), including any inventory optimization program and/or any curtailment, any business optimization charge, any restructuring charge (including any charges relating to any tax restructuring), any charge relating to the closure or consolidation of any office or facility (including but not limited to rent termination costs, moving costs and legal costs), any systems implementation charge, any severance charge, any one time compensation charge, any charge relating to entry into a new market, any charge relating to any strategic initiative or contract, any charge relating to any entry into new markets and contracts, any lease run-off charge, any charge associated with improvements to information technology (IT) or accounting functions, losses related to temporary decreases in work volume and expenses related to maintaining underutilized personnel, any charge relating to a new contract, any consulting charge and/or any corporate development charge; provided, that, in the case of any such charge, the results of any such action relating to such charge are projected by in good faith to be achieved within 24 months of the undertaking.

4 The adjustment for extraordinary unusual non-recurring gains or losses is to remove extraordinary gains and losses, which include any gain or charge from any extraordinary item as determined in good faith by the Company and/or any non-recurring or unusual item as determined in good faith by the Company and/or any charge associated with and/or payment of any legal settlement, fine, judgment or order.

Chart for Trailing Fifty-Two Week Net Loss & Adjusted EBITDA is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d77b5c05-9244-4376-b674-a51da0db1868

 

TRAILING 52-WEEK ADJUSTED EBITDA RECONCILIATION
Fifty-two week Net (loss) income and Adjusted EBITDA
(in thousands) December 29, 2019 December 27, 2020 March 28, 2021 June 27, 2021 September 26, 2021 December 26, 2021
Net (loss) income   (1,841 )     (167,530 )     (197,748 )     (126,461 )     (70,125 )     (55,442 )  
Adjustments:            
Interest expense   69,903     84,598     86,352     88,857     90,612     92,239  
Income tax expense (benefit)   1,803     8,187     7,927     (1,035)     (7,403)     (7,147)  
Depreciation and amortization   89,264     91,349     91,411     91,851     92,241     95,363  
Share-based compensation   3,406     3,255     3,226     3,164     3,116     44,975  
Closed center EBITDA [1]   (400)     3,482     3,259     4,039     3,880     3,374  
Foreign currency exchange (gain) loss   (225)     59     (146)     (188)     (155)     126  
Asset disposition loss (gain)   5,247     920     613     (46)     (77)     (58)  
Transactional and other advisory costs [2]   3,041     5,208     5,573     10,737     12,056     40,474  
Charges attributed to new initiatives [3]   1,020     543     500     531     540     489  
Extraordinary unusual non-recurring losses [4]   2,680     (2,501)     360     1,670     65     3,374  
Changes in the value of earnouts and warrants   0     0     0     0     0     (22,472)  
ADJUSTED EBITDA   $ 173,898     $ 27,570     $ 1,327     $ 73,119     $ 124,750     $ 195,295  

1 The closed center adjustment is to remove EBITDA for closed centers. Closed centers are those centers that are closed for a variety of reasons, including permanent closure, newly acquired or built centers prior to opening, centers closed for renovation or rebranding and conversion. Closed centers do not include centers closed in compliance with local, state and federal government restrictions due to COVID-19. If a center is not open on the last day of the reporting period, it will be considered closed for that reporting period. If the center is closed on the first day of the reporting period for permanent closure, the center will be considered closed for that reporting period.

2 The adjustment for transaction costs and other advisory costs is to remove charges incurred in connection with any transaction, including mergers, acquisitions, refinancing, amendment or modification to indebtedness, dispositions and costs in connection with an initial public offering, in each case, regardless of whether consummated.

3 The adjustment for charges is to remove charges attributed to new initiatives include charges with the undertaking and/or implementation of new initiatives, business optimization activities, cost savings initiatives, cost rationalization programs, operating expense reductions and/or synergies and/or similar initiatives and/or programs (including in connection with any integration, restructuring or transition, any reconstruction, decommissioning, recommissioning or reconfiguration of fixed assets for alternative uses, any office or facility opening and/or pre-opening), including any inventory optimization program and/or any curtailment, any business optimization charge, any restructuring charge (including any charges relating to any tax restructuring), any charge relating to the closure or consolidation of any office or facility (including but not limited to rent termination costs, moving costs and legal costs), any systems implementation charge, any severance charge, any one time compensation charge, any charge relating to entry into a new market, any charge relating to any strategic initiative or contract, any charge relating to any entry into new markets and contracts, any lease run-off charge, any charge associated with improvements to information technology (IT) or accounting functions, losses related to temporary decreases in work volume and expenses related to maintaining underutilized personnel, any charge relating to a new contract, any consulting charge and/or any corporate development charge; provided, that, in the case of any such charge, the results of any such action relating to such charge are projected by in good faith to be achieved within 24 months of the undertaking.

4 The adjustment for extraordinary unusual non-recurring gains or losses is to remove extraordinary gains and losses, which include any gain or charge from any extraordinary item as determined in good faith by the Company and/or any non-recurring or unusual item as determined in good faith by the Company and/or any charge associated with and/or payment of any legal settlement, fine, judgment or order.

 

NORMALIZED NET INCOME RECONCILIATION
Thirteen week Net (loss) income
(in thousands) December 26, 2021
Net (loss) income ($ 34,454 )  
   
Share-based compensation – de-SPAC $42,212  
Change in FV of earnouts and warrants ($22,472)  
Transactional and other advisory costs – de-SPAC $29,149  
   
Normalized Net Income $ 14,435  
   

Non-GAAP Financial Measures

To provide investors with information in addition to our results as determined under Generally Accepted Accounting Principles (“GAAP”), we disclose net income, normalized for extraordinary and non-recurring items related to the de-SPAC transaction, Adjusted EBITDA and trailing fifty-two week Adjusted EBITDA as “non-GAAP measures” which management believes provide useful information to investors because each measure assists both investors and management in analyzing and benchmarking the performance and value of our business. Accordingly, management believes that these measurements are useful for comparing general operating performance from period to period, and management relies on these measures for planning and forecasting of future periods. Additionally, these measures allow management to compare our results with those of other companies that have different financing and capital structures. These measures are not financial measures calculated in accordance with GAAP and should not be considered as a substitute for revenue, net income, net cash provided (used) by operating activities or any other operating performance or liquidity measure calculated in accordance with GAAP, and may not be comparable to a similarly titled measure reported by other companies.

Net income normalized for extraordinary and non-recurring items related to the de-SPAC transaction represents Net income (loss) before share-based compensation issued in connection with the Company’s de-SPAC transaction and transaction and other advisory costs related to the de-SPAC transaction. Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“Adjusted EBITDA”) represents Net income (loss) before Interest, Income Taxes, Depreciation and Amortization, Share-based Compensation, EBITDA from Closed Centers, Foreign Currency Exchange Loss (Gain), Asset Disposition Loss (Gain), Transactional and other advisory costs, Charges attributed to new initiatives, Extraordinary unusual non-recurring gains or losses and Changes in the value of earnouts and warrants. Trailing fifty-two week Adjusted EBITDA represents Adjusted EBITDA over the most recent fifty-two week period.

The Company considers net income normalized for extraordinary and non-recurring items related to the de-SPAC transaction as an important financial measure because it provides an indicator of performance that is not affected by fluctuations in certain costs or other items. However, this measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that it does not reflect every cash expenditure and is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows.

The Company considers Adjusted EBITDA as an important financial measure because it provides a financial measure of the quality of the Company’s earnings. Other companies may calculate Adjusted EBITDA differently than we do, which might limit its usefulness as a comparative measure. Adjusted EBITDA is used by management in addition to and in conjunction with the results presented in accordance with GAAP. Additionally, we believe trailing fifty-two week Adjusted EBITDA provides the current run-rate for trending purposes, rather than annualizing the respective quarters, as the Company’s business is seasonal, with the second and third fiscal quarters being higher than the first and last quarters.

We have presented Adjusted EBITDA solely as a supplemental disclosure because we believe it allows for a more complete analysis of results of operations and assists investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance, such as Interest, Income Taxes, Depreciation and Amortization, Share-based Compensation, EBITDA from Closed Centers, Foreign Currency Exchange Loss (Gain), Asset Disposition Loss (Gain), Transactional and other advisory costs, Charges attributed to new initiatives, Extraordinary unusual non-recurring gains or losses and Changes in the value of earnouts and warrants.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that Adjusted EBITDA and trailing fifty-two week Adjusted EBITDA:

  • do not reflect every expenditure, future requirements for capital expenditures or contractual commitments;
  • do not reflect changes in our working capital needs;
  • do not reflect the interest expense, or the amounts necessary to service interest or principal payments, on our outstanding debt;
  • do not reflect income tax (benefit) expense, and because the payment of taxes is part of our operations, tax expense is a necessary element of our costs and ability to operate;
  • do not reflect non-cash equity compensation, which will remain a key element of our overall equity based compensation package; and
  • do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations.

Contacts:

For Media:
Jillian Laufer
JLaufer@BowleroCorp.com

For Investors:
ICR, Inc.
Ryan Lawrence
Ryan.Lawrence@icrinc.com

Ashley DeSimone
Ashley.desimone@icrinc.com

1 “GAAP” stands for Generally Accepted Accounting Principles in the U.S. Please see the sections of this document titled “GAAP Financial Statements” and “GAAP to non-GAAP Reconciliations” for more information on the Company’s GAAP and non-GAAP measures. Certain figures in the tables throughout this document may not foot due to rounding.
2 Total Bowling Center Revenue excludes closed bowling center activity and media revenue, which is also a component of our bowling operations. For weeks between 9/5/21 and 12/26/21, the percentages above are calculated by comparing each week to the comparable week in 2019. For weeks after 12/26/21, the percentages above are calculated by comparing each week to the comparable week in 2020. Data for all weeks following the close of the quarter ended on 12/26/21 are preliminary.

Source: Bowlero Corp

CoreCivic Inc. (CXW) – Solid 4Q21 Provides Guidance for 2022

Thursday, February 10, 2022

CoreCivic, Inc. (CXW)
Solid 4Q21, Provides Guidance for 2022

CoreCivic is a diversified government solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. We provide a broad range of solutions to government partners that serve the public good through corrections and detention management, a growing network of residential reentry centers to help address America’s recidivism crisis, and government real estate solutions. We are a publicly traded real estate investment trust and the nation’s largest owner of partnership correctional, detention and residential reentry facilities. We also believe we are the largest private owner of real estate used by U.S. government agencies. The Company has been a flexible and dependable partner for government for more than 35 years. Our employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    4Q21 Results. CoreCivic reported fourth quarter results after the market closed yesterday. Revenue came in at $472.1 million, compared to $473.5 million in the same period last year. The Company reported net income of $28 million, or $0.23 per share, compared to a loss of $26.8 million, or $0.22 per share last year. Adjusted EPS of $0.27 compared to $0.40. On a proforma basis to reflect the adoption of a C-corp structure EPS was $0.27 versus $0.30 last year. We had projected revenue of $474 million and EPS of $0.22.

    2021 Results.  Full year revenue came in at $1.86 billion, adjusted EPS at $1.04, normalized FFO at $1.85, and adjusted EBITDA at $402 million. These results were obtained in the still challenging operating environment, including Covid-related costs and restrictions and the loss of USMS contracts as a result of the President’s executive order. In 2020, revenue was $1.91 billion, adjusted EPS$1.32 …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – Schwazze Closes Acquisition Of Emerald Fields



Schwazze Closes Acquisition Of Emerald Fields

Research, News, and Market Data on Schwazze

 

Schwazze Continues Colorado Expansion Strategy with
Emerald Fields Cannaboutique Dispensaries in Manitou Springs & Glendale, CO

DENVER, CO – February 10, 2022 – Schwazze, (OTCQX:SHWZ) (“Schwazze” or the “Company”), announced today that it has closed the transaction to acquire MCG, LLC (“Emerald Fields”). Emerald Fields is the owner and operator of two retail cannabis dispensaries, located in Manitou Springs and Glendale, Colorado. This successful acquisition is part of the Company’s ongoing retail expansion plan in Colorado and New Mexico, bringing the total number of dispensaries the Company operates to 32.

Total consideration for the acquisition is $29 million and will be paid as 60% cash and 40% Schwazze common stock upon closing. This is an estimated 3.8 multiple on 2021 Adjusted EBITDA(1).

“Our team is delighted to add the Emerald Fields Cannaboutiques to our growing portfolio of dispensaries and are eager to welcome the team to Schwazze. Manitou Springs and Glendale are attractive locations and valuable assets to our overall growth plan as we continue to build out Colorado. Our team is excited to add another store brand to our house of brands.” said Justin Dye, Schwazze’s CEO.

About Schwazze

Schwazze (OTCQX: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices. Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc.

Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.

Forward-Looking Statements

This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,”, “predicts,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, (x) the timing and extent of governmental stimulus programs, (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws, and (x) out ability to satisfy the closing conditions for the private finding described in this press release. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

(1) Adjusted EBITDA represents income (loss) from operations, as reported, before tax, adjusted to exclude non-recurring items, other non-cash items, including stock-based compensation expense, depreciation, and amortization, and further adjusted to remove acquisition related costs, and other one-time expenses, such as severance. The Company uses adjusted EBITDA as it believes it better explains the results of its core business. The Company has not reconciled guidance for adjusted EBITDA to the corresponding GAAP financial measure because it cannot provide guidance for the various reconciling items. The Company is unable to provide guidance for these reconciling items because it cannot determine their probable significance, as certain items are outside of its control and cannot be reasonably predicted. Accordingly, a reconciliation to the corresponding GAAP financial measure is not available without unreasonable effort.

Investors
Joane Jobin
Investor Relations
Joanne.jobin@schwazze.com
647-964-0292

Media
Julie Suntrup, Schwazze
Vice President | Marketing & Merchandising
julie.suntrup@schwazze.com
303-371-0387

Release – Comstock Urges U.S. EPA To Expand Renewable Fuel Incentives For Biointermediates



Comstock Urges U.S. EPA To Expand Renewable Fuel Incentives For Biointermediates

Research, News, and Market Data on Comstock Mining

 

Technologies Enable Dramatic Reduction in Carbon Intensity for America’s Decarbonization Portfolio

VIRGINIA CITY, NEVADA, FEBRUARY 10, 2022 – Comstock Mining Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced its submission of comments to the U.S. Environmental Protection Agency (“EPA”) calling for enhanced regulations governing the use of biomass-derived intermediates in the production of renewable fuels that qualify for federal incentives under the EPA’s Renewable Fuel Standard (“RFS”).

Comstock’s patented, patent-pending and proprietary portfolio of breakthrough Cellulosic Fuels technologies efficiently converts wasted, unused, widely-available, and rapidly-replenishable woody biomass into intermediates for the production of carbon neutral gasoline, renewable diesel, sustainable aviation fuel, marine fuel, ethanol, oils and other advanced renewable replacements for fossil fuel products.

“Our technologies broadly enable a powerful new feedstock model for multiple renewable fuel platforms by converting wasted and under-utilized woody biomass into biointermediates, including cellulosic sugar and a mixture of hydrocarbons called biocrude,” said Corrado De Gasperis, Comstock’s executive chairman and chief executive officer. “Our cellulosic sugar products are chemically identical to pure glucose, and capable of directly offsetting corn as a feedstock for fermentation in existing ethanol facilities. Likewise, our biocrude products have specifications that are similar to fossil crude, and are qualified for refining into drop-in fuels, such as gasoline, renewable diesel, sustainable aviation fuel, and marine fuel.”

Removing Limitations for Breakthrough Technologies

Under the current regulatory structure, Comstock would directly produce and sell renewable fuels to qualify for federal incentives under the RFS. However, the EPA proposed modifications to the RFS in December 2021 to accommodate the growing potential of using biointermediates in the production of renewable fuels. Comstock’s February 2022 comments to the EPA supported and urged inclusion of the full range of America’s available woody biomass resources to produce biointermediates for sale to multiple downstream renewable fuel producers, thereby expediting the transition from petroleum to renewable fuels, and enabling the transformational changes envisioned by the Biden Administration to address the challenges of climate change. Comstock also urged the EPA to revise the renewable identification number (“RIN”) program to create ambitious additional categories for new and emerging technologies that can achieve 80%, 100%, and 120% greenhouse gas (“GHG”) reductions, as compared to the existing 60% cap on GHG reduction in the current RIN program, to fairly incentivize and accelerate transformational change.

Transformational Economic Benefits

Comstock’s technologies can produce enough cellulosic sugar and biocrude to refine more than 70,000,000 gallons of ethanol and 30,000,000 gallons of renewable diesel from each 1,000,000 dry tons of woody biomass. For context, according to the U.S. Department of Energy, America has the potential to produce upwards of one billion dry tons of biomass per year, substantially comprised of wasted and under-utilized forestry and agricultural residuals that Comstock’s proven and shovel-ready Cellulosic Fuels technologies have the ability to convert into biointermediates.

“We plan to be extremely active in America’s wood basket,” added De Gasperis. “America has tremendous untapped reserves of woody biomass and under-utilized forestry and agricultural resources that could be simultaneously used to stimulate transformational economic and environmental change, by adding significant additional revenue and jobs into America’s rural economies, while producing biointermediate and other products that dramatically reduce GHG emissions as compared to conventional renewable fuel feedstocks. While we are prepared to use our technologies to directly produce renewable fuels, we can grow much faster and achieve far greater gains by producing and selling biointermediates to other renewable fuel producers. We are excited by EPA’s timely focus on these important regulations.”

Comstock’s team has extensive experience in the renewable fuel industry, having designed and built numerous biointermediate and renewable fuel production facilities in the United States. Most notably, Comstock’s team invented and commercialized processes used by more than 95% of the U.S. corn ethanol industry to produce distillers corn oil, a value-added biointermediate that has played a vital role in the growth and development of the corn ethanol, biodiesel, and renewable diesel industries. Comstock plans to apply this expertise to building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, with several potential sites currently under evaluation for development.

About Comstock Mining Inc.

Comstock Mining Inc. (NYSE: LODE) (the “Company”) innovates technologies that contribute to global decarbonization and circularity by shifting the consumption patterns of industries and populations. Comstock’s technologies are designed to do so by efficiently converting wasted and unused natural resources into valuable renewable energy products. Comstock intends to use its technologies to achieve exponential growth and extraordinary financial, natural and social gains by building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, by selling an array of complimentary process solutions and related services, and by licensing selected technologies to qualified strategic partners. To learn more, please visit www.comstockmining.com.

Forward-Looking Statements

This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: future industry market conditions; future explorations or acquisitions; future changes in our exploration activities; future prices and sales of, and demand for, our products; land entitlements and uses; permits; production capacity and operations; operating and overhead costs; future capital expenditures and their impact on us; operational and management changes (including changes in the Board of Directors); changes in business strategies, planning and tactics; future employment and contributions of personnel, including consultants; future land sales; investments, acquisitions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives, including the nature, timing and accounting for restructuring charges, derivative assets and liabilities and the impact thereof; contingencies; litigation, administrative or arbitration proceedings; environmental compliance and changes in the regulatory environment; offerings, limitations on sales or offering of equity or debt securities, including asset sales and associated costs; and future working capital, costs, revenues, business opportunities, debt levels, cash flows, margins, taxes, earnings and growth. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in our filings with the SEC and the following: adverse effects of climate changes or natural disasters; adverse effects of global or regional pandemic disease spread or other crises; global economic and capital market uncertainties; the speculative nature of gold or mineral exploration, mercury remediation and lithium, nickel and cobalt recycling, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration or mercury remediation, metal recycling, processing or mining activities; costs, hazards and uncertainties associated with precious metal based activities, including environmentally friendly and economically enhancing clean mining and processing technologies, precious metal exploration, resource development, economic feasibility assessment and cash generating mineral production; costs, hazards and uncertainties associated with mercury remediation, metal recycling, processing or mining activities; contests over our title to properties; potential dilution to our stockholders from our stock issuances, recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting our businesses; permitting constraints or delays; ability to achieve the benefits of business opportunities that may be presented to, or pursued by, us, including those involving battery technology, mercury remediation technology and efficacy, quantum computing and advanced materials development, and development of cellulosic technology in bio-fuels and related carbon-based material production; ability to successfully identify, finance, complete and integrate acquisitions, joint ventures, strategic alliances, business combinations, asset sales, and investments that we may be party to in the future; changes in the United States or other monetary or fiscal policies or regulations; interruptions in our production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such as silver, zinc, lithium, nickel, cobalt, cyanide, water, diesel, gasoline and alternative fuels and electricity); changes in generally accepted accounting principles; adverse effects of war, mass shooting, terrorism and geopolitical events; potential inability to implement our business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors; assertion of claims, lawsuits and proceedings against us; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the Securities and Exchange Commission; potential inability to list our securities on any securities exchange or market or maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows, or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Neither this press release nor any related calls or discussions constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer.

 

Contact information:

Comstock Mining Inc.
P.O. Box 1118
Virginia City, NV 89440
ComstockMining.com
Corrado De Gasperis
Executive Chairman & CEO
Tel (775) 847-4755
degasperis@comstockmining.com
Zach Spencer
Director of External Relations
Tel (775) 847-5272 Ext.151
questions@comstockmining.com

Release – CoreCivic Reports Fourth Quarter and Full Year 2021 Financial Results



CoreCivic Reports Fourth Quarter and Full Year 2021 Financial Results

Research, News, and Market Data on CoreCivic

 

BRENTWOOD, Tenn., Feb. 09, 2022 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (the Company) announced today its financial results for the fourth quarter and full year 2021.

Financial Highlights – Full Year 2021

  • Total revenue of $1.86 billion
    • CoreCivic Safety revenue of $1.69 billion
    • CoreCivic Community revenue of $99.4 million
    • CoreCivic Properties revenue of $68.9 million
  • Net loss attributable to common stockholders of $51.9 million
  • Net loss reflects $178.6 million of special items, including $114.2 million of income taxes associated with change in corporate tax structure reflected in the first quarter of 2021
  • Diluted net loss per share of $0.43
  • Adjusted diluted EPS of $1.04
  • Normalized FFO per diluted share of $1.85
  • Adjusted EBITDA of $402.0 million

Damon T. Hininger, CoreCivic’s President and Chief Executive Officer, said, “Our fourth quarter financial performance capped off another year of resilient cash flow generation amid the ongoing global pandemic.   During 2021, we made great strides in enhancing our capital structure by revoking our REIT election, selling non-core assets which enabled us to accelerate our debt reduction strategy, accessed the debt capital markets, extended our debt maturities, and positioned our balance sheet to allow us to pursue attractive growth opportunities and return capital to shareholders. With the financial guidance we are providing today for the full year 2022, our capital allocation strategy remains on track.

Hininger continued, “We began 2022 on a positive note with the recent announcement of our new contract with the state of Arizona to care for up to 2,706 inmates at our La Palma Correctional Center, which is the largest contract awarded to the private sector by any state in over a decade.   We look to continue this positive momentum as we pursue other market opportunities that may present themselves throughout the year.”

Financial Highlights – Fourth Quarter 2021

  • Total revenue of $472.1 million
    • CoreCivic Safety revenue of $432.8 million
    • CoreCivic Community revenue of $25.3 million
    • CoreCivic Properties revenue of $14.0 million
  • Net income attributable to common stockholders of $28.0 million
  • Diluted earnings per share of $0.23
  • Adjusted diluted EPS of $0.27
  • Normalized FFO per diluted share of $0.48
  • Adjusted EBITDA of $103.2 million

Fourth Quarter 2021 Financial Results Compared With Fourth Quarter 2020

Net income attributable to common stockholders in the fourth quarter of 2021 totaled $28.0 million, or $0.23 per diluted share, compared with net loss attributable to common stockholders in the fourth quarter of 2020 of $26.8 million, or a net loss of $0.22 per diluted share. Adjusted for special items, net income in the fourth quarter of 2021 was $32.6 million, or $0.27 per diluted share (Adjusted Diluted EPS), compared with adjusted net income in the fourth quarter of 2020 of $48.8 million, or $0.40 per diluted share. Special items for each period are presented in detail in the calculation of Adjusted Diluted EPS in the Supplemental Financial Information following the financial statements presented herein. Financial results in 2021 reflect higher income tax expense following the revocation of our election to be taxed as a real estate investment trust (REIT) effective January 1, 2021. As a REIT, we were entitled to a deduction for dividends paid, which resulted in a significantly lower income tax expense in the prior year. The decline in per share amounts was also the result of property sales and refinancing transactions, both of which strengthened our balance sheet, as well as an increase in general and administrative (G&A) expenses.

Earnings before interest, taxes, depreciation and amortization (EBITDA) was $97.0 million in the fourth quarter of 2021, compared with $33.0 million in the fourth quarter of 2020. Adjusted EBITDA, which excludes special items, was $103.2 million in the fourth quarter of 2021, compared with $108.7 million in the fourth quarter of 2020. Adjusted EBITDA decreased from the prior year quarter due to the sale of 47 non-core real estate assets since the end of the third quarter of 2021, which generated $7.4 million in Adjusted EBITDA in the fourth quarter of 2020, and an increase in G&A expenses primarily resulting from lower incentive compensation in the prior year due to the onset of COVID-19.  

Funds From Operations (FFO) was $54.7 million, or $0.45 per diluted share, in the fourth quarter of 2021, compared to $22.8 million, or $0.19 per diluted share, in the fourth quarter of 2020. Normalized FFO, which excludes special items, was $57.8 million, or $0.48 per diluted share, in the fourth quarter of 2021, compared with $76.3 million, or $0.63 per diluted share, in the fourth quarter of 2020. FFO and Normalized FFO were also impacted by our new corporate tax structure.

Adjusted Net Income, EBITDA, Adjusted EBITDA, FFO, and Normalized FFO, and, where appropriate, their corresponding per share amounts, are measures calculated and presented on the basis of methodologies other than in accordance with generally accepted accounting principles (GAAP). Please refer to the Supplemental Financial Information and related note following the financial statements herein for further discussion and reconciliations of these measures to net income, the most directly comparable GAAP measure.

Business Updates

New Contract with the State of Arizona at the La Palma Correctional Center. On January 10, 2022, we announced that we were awarded a new contract with the state of Arizona to care for up to 2,706 adult male inmates on behalf of the Arizona Department of Corrections, Rehabilitation & Reentry (ADCRR) at the Company’s 3,060-bed La Palma Correctional Center in Eloy, Arizona. The new management contract has an initial term of five years, with one extension option for up to five years thereafter upon mutual agreement. We are currently working with ADCRR on a ramp plan that is expected to begin late in the first quarter or early in the second quarter of 2022. The La Palma facility currently supports the mission of Immigration and Customs Enforcement (ICE) by caring for approximately 1,800 detainees. We are simultaneously working with ICE to coordinate the transition of their populations to other facilities, including at facilities where we have available capacity within the region. We expect the transition of populations from ICE detainees to inmates from the state of Arizona to result in the disruption of earnings and cash flows until the occupancy of inmates from the state of Arizona reaches stabilization. Upon full utilization of the new contract with the state of Arizona we expect to generate approximately $75 million to $85 million in annualized revenue at the La Palma facility.  

2022 Financial Guidance

Based on current business conditions, the Company is providing the following financial guidance for the full year 2022:

  Full Year 2022
• Diluted EPS $0.72 to $0.86
• FFO per diluted share $1.55 to $1.70
• EBITDA $354.8 million to $370.0 million

Our 2022 guidance reflects a continuation of occupancy restrictions placed on our bed capacity by many of our government partners as a result of the ongoing COVID-19 pandemic, which could result in enhanced earnings when relieved. Our 2022 guidance also reflects the aforementioned transition of resident populations at our La Palma Correctional Center, and higher operating expenses due to above average wage inflation we expect to experience in 2022 as a result of the challenging labor market.

During 2022, we expect to invest approximately $75.8 million to $79.3 million in capital expenditures, consisting of approximately $33.8 million to $34.3 million in maintenance capital expenditures on real estate assets; $30.0 million to $32.0 million for capital expenditures on other assets and information technology and $12.0 million to $13.0 million for facility renovations.

Supplemental Financial Information and Investor Presentations

We have made available on our website supplemental financial information and other data for the fourth quarter and full year 2021.   Interested parties may access this information through our website at http://ir.corecivic.com/ under “Financial Information” of the Investors section.   We do not undertake any obligation and disclaim any duties to update any of the information disclosed in this report.  

Management may meet with investors from time to time during the first quarter of 2022.   Written materials used in the investor presentations will also be available on our website beginning on or about February 21, 2022.   Interested parties may access this information through our website at http://ir.corecivic.com/ under “Events & Presentations” of the Investors section.

Conference Call, Webcast and Replay Information

We will host a webcast conference call at 10:00 a.m. central time (11:00 a.m. eastern time) on Thursday, February 10, 2022, which will be accessible through the Company’s website at www.corecivic.com under the “Events & Presentations” section of the “Investors” page. The live broadcast can also be accessed by dialing 877-614-0009 in the U.S. and Canada, including the confirmation passcode 8591205. An online replay of the call will be archived on our website promptly following the conference call. In addition, there will be a telephonic replay available beginning at 1:15 p.m. central time (2:15 p.m. eastern time) on February 10, 2022, through 1:15 p.m. central time (2:15 p.m. eastern time) on February 18, 2022. To access the telephonic replay, dial 888-203-1112 in the U.S. and Canada. International callers may dial +1 719-457-0820 and enter passcode 8591205.

About CoreCivic

CoreCivic is a diversified government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. CoreCivic provides a broad range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address America’s recidivism crisis, and government real estate solutions. CoreCivic is the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and believes it is the largest private owner of real estate used by government agencies in the U.S. CoreCivic has been a flexible and dependable partner for government for more than 35 years. CoreCivic’s employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good.

Forward-Looking Statements

This press release contains statements as to our beliefs and expectations of the outcome of future events that are “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. These include, but are not limited to, the risks and uncertainties associated with: (i) changes in government policy (including the United States Department of Justice, or DOJ, not renewing contracts as a result of President Biden’s Executive Order on Reforming Our Incarceration System to Eliminate the Use of Privately Operated Criminal Detention Facilities, or the Private Prison EO) (two agencies of the DOJ, the United States Federal Bureau of Prisons and the United States Marshals Service utilize our services), legislation and regulations that affect utilization of the private sector for corrections, detention, and residential reentry services, in general, or our business, in particular, including, but not limited to, the continued utilization of our correctional and detention facilities by the federal government, and the impact of any changes to immigration reform and sentencing laws (our company does not, under longstanding policy, lobby for or against policies or legislation that would determine the basis for, or duration of, an individual’s incarceration or detention); (ii) our ability to obtain and maintain correctional, detention, and residential reentry facility management contracts because of reasons including, but not limited to, sufficient governmental appropriations, contract compliance, negative publicity and effects of inmate disturbances; (iii) changes in the privatization of the corrections and detention industry, the acceptance of our services, the timing of the opening of new facilities and the commencement of new management contracts (including the extent and pace at which new contracts are utilized), as well as our ability to utilize available beds; (iv) general economic and market conditions, including, but not limited to, the impact governmental budgets can have on our contract renewals and renegotiations, per diem rates, and occupancy; (v) fluctuations in our operating results because of, among other things, changes in occupancy levels; competition; contract renegotiations or terminations; inflation and other increases in costs of operations, including a continuing rise in labor costs; fluctuations in interest rates and risks of operations; (vi) the duration of the federal government’s denial of entry at the United States southern border to asylum-seekers and anyone crossing the southern border without proper documentation or authority in an effort to contain the spread of COVID-19; (vii) government and staff responses to staff or residents testing positive for COVID-19 within public and private correctional, detention and reentry facilities, including the facilities we operate; (viii)  restrictions associated with COVID-19 that disrupt the criminal justice system, along with government policies on prosecutions and newly ordered legal restrictions that affect the number of people placed in correctional, detention, and reentry facilities, including those associated with a resurgence of COVID-19; (ix) whether revoking our REIT election, effective January 1, 2021, and our revised capital allocation strategy can be implemented in a cost effective manner that provides the expected benefits, including facilitating our planned debt reduction initiative and planned return of capital to shareholders; (x) our ability to successfully identify and consummate future development and acquisition opportunities and realize projected returns resulting therefrom; (xi) our ability, following our revocation of our REIT election, to identify and initiate service opportunities that were unavailable under the REIT structure; (xii) our ability to have met and maintained qualification for taxation as a REIT for the years we elected REIT status; and (xiii) the availability of debt and equity financing on terms that are favorable to us, or at all. Other factors that could cause operating and financial results to differ are described in the filings we make from time to time with the Securities and Exchange Commission.

CoreCivic takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release or the information contained herein by any third-parties, including, but not limited to, any wire or internet services.


CORECIVIC, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

ASSETS   December 31,
2021
  December 31,
2020
         
Cash and cash equivalents   $ 299,645     $ 113,219  
Restricted cash     11,062       23,549  
Accounts receivable, net of credit loss reserve of $7,931 and $6,103, respectively     282,809       267,705  
Prepaid expenses and other current assets     26,872       33,243  
Assets held for sale     6,996       279,406  
Total current assets     627,384       717,122  
Real estate and related assets:        
Property and equipment, net of accumulated depreciation of $1,657,709 and $1,559,388, respectively     2,283,256       2,350,272  
Other real estate assets     218,915       228,243  
Goodwill     4,844       5,902  
Non-current deferred tax assets           11,113  
Other assets     364,539       396,663  
         
Total assets   $ 3,498,938     $ 3,709,315  
         
LIABILITIES AND STOCKHOLDERS’ EQUITY        
         
Accounts payable and accrued expenses   $ 305,592     $ 274,318  
Current portion of long-term debt     35,376       39,087  
Total current liabilities     340,968       313,405  
         
Long-term debt, net     1,492,046       1,747,664  
Deferred revenue     27,551       18,336  
Non-current deferred tax liabilities     88,157        
Other liabilities     177,748       216,468  
         
Total liabilities     2,126,470       2,295,873  
         
Commitments and contingencies        
         
Preferred stock ? $0.01 par value; 50,000 shares authorized; none issued and outstanding at December 31, 2021 and 2020, respectively            
Common stock ? $0.01 par value; 300,000 shares authorized; 120,285 and 119,638 shares issued and outstanding at December 31, 2021 and 2020, respectively     1,203       1,196  
Additional paid-in capital     1,869,955       1,835,494  
Accumulated deficit     (498,690 )     (446,519 )
Total stockholders’ equity     1,372,468       1,390,171  
Non-controlling interest – operating partnership           23,271  
Total equity     1,372,468       1,413,442  
         
Total liabilities and stockholders’ equity   $ 3,498,938     $ 3,709,315  
                 

CORECIVIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

    For the Three Months Ended
December 31,
  For the Year Ended
December 31,
      2021       2020       2021       2020  
                 
REVENUES:                
Safety   $ 432,785     $ 424,318     $ 1,693,968     $ 1,706,232  
Community     25,313       25,320       99,435       105,990  
Properties     14,007       23,802       68,934       93,098  
Other     28       37       279       165  
      472,133       473,477       1,862,616       1,905,485  
                 
EXPENSES:                
Operating                
Safety     309,948       315,127       1,236,938       1,288,938  
Community     20,059       21,158       81,610       88,903  
Properties     2,832       6,857       18,155       28,128  
Other     80       65       362       407  
Total operating expenses     332,919       343,207       1,337,065       1,406,376  
General and administrative     38,412       27,031       135,770       124,338  
Depreciation and amortization     33,951       36,425       134,738       150,861  
Contingent consideration for acquisition of businesses                       620  
Shareholder litigation expense                 54,295        
Asset impairments     2,027       47,570       11,378       60,628  
      407,309       454,233       1,673,246       1,742,823  
                 
OTHER INCOME (EXPENSE):                
Interest expense, net     (23,239 )     (19,572 )     (85,542 )     (83,299 )
Expenses associated with debt repayments and refinancing transactions     (4,112 )     (7,141 )     (56,279 )     (7,141 )
Gain (loss) on sale of real estate assets, net           (17,943 )     38,766       (13,023 )
Other income (expense)     (105 )     (188 )     (212 )     525  
                 
INCOME (LOSS) BEFORE INCOME TAXES     37,368       (25,600 )     86,103       59,724  
                 
Income tax expense     (9,331 )     (1,203 )     (137,999 )     (4,386 )
NET INCOME (LOSS)     28,037       (26,803 )     (51,896 )     55,338  
                 
Net income attributable to non-controlling interest              –                   (1,181 )
                 
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS   $ 28,037     $ (26,803 )   $ (51,896 )   $ 54,157  
                 
                 
BASIC EARNINGS (LOSS) PER SHARE   $  0.23     $ (0.22 )   $  (0.43 )   $ 0.45  
                 
DILUTED EARNINGS (LOSS) PER SHARE   $ 0.23     $ (0.22 )   $ (0.43 )   $ 0.45  
                                 

CORECIVIC, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

CALCULATION OF ADJUSTED NET INCOME AND ADJUSTED DILUTED EPS

  For the Three Months Ended
December 31,
  For the Year Ended
December 31,
    2021       2020       2021       2020
               
Net income (loss) attributable to common stockholders $ 28,037     $ (26,803 )   $ (51,896 )   $ 54,157
Non-controlling interest                     1,181
Diluted net income (loss) attributable to common stockholders $ 28,037     $ (26,803 )   $ (51,896 )   $ 55,338
                             
Special items:                            
Expenses associated with debt repayments and refinancing transactions   4,112       7,141       56,279       7,141
Expenses associated with mergers and acquisitions                     338
Expenses associated with COVID-19         2,792       2,434       13,777
Expenses associated with changes in corporate tax structure         195             5,240
Income taxes associated with change in corporate tax structure and other special tax items               114,249       3,085
Contingent consideration for acquisition of businesses                     620
Loss (gain) on sale of real estate assets, net         17,943       (38,766 )     13,023
Shareholder litigation expense               54,295      
Asset impairments   2,027       47,570       11,378       60,628
Income tax expense (benefit) for special items   (1,533 )           (21,227 )     532
Adjusted net income $ 32,643     $ 48,838     $ 126,746     $ 159,722
Weighted average common shares outstanding – basic   120,285       119,636       120,192       119,559
Effect of dilutive securities:                            
Restricted stock-based awards   933       56       531       28
Non-controlling interest – operating partnership units         1,342       952       1,342
Weighted average shares and assumed conversions – diluted   121,218       121,034       121,675       120,929
Adjusted Earnings Per Diluted Share $ 0.27     $ 0.40     $ 1.04     $ 1.32
                             

CORECIVIC, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

CALCULATION OF FUNDS FROM OPERATIONS AND NORMALIZED FUNDS FROM OPERATIONS

  For the Three Months Ended
December 31,
  For the Year Ended
December 31,
    2021       2020       2021       2020
               
Net income (loss) $ 28,037     $ (26,803 )   $ (51,896 )   $ 55,338
Depreciation and amortization of real estate assets   25,176       27,447       98,738       112,046
Impairment of real estate assets   2,027       4,225       3,335       14,380
Loss (gain) on sale of real estate assets, net         17,943       (38,766 )     13,023
Income tax expense for special items   (506 )           8,785       532
Funds From Operations $ 54,734     $ 22,812     $ 20,196     $ 195,319
                             
Expenses associated with debt repayments and refinancing transactions   4,112       7,141       56,279       7,141
Expenses associated with mergers and acquisitions                     338
Contingent consideration for acquisition of businesses                     620
Expenses associated with COVID-19         2,792       2,434       13,777
Expenses associated with changes in corporate tax structure         195             5,240
Income taxes associated with change in corporate tax structure and other special tax items               114,249       3,085
Shareholder litigation expense               54,295      
Goodwill and other impairments         43,345       8,043       46,248
Income tax benefit for special items   (1,027 )           (30,012 )    
Normalized Funds From Operations $ 57,819     $ 76,285     $ 225,484     $ 271,768
                             
Funds From Operations Per Diluted Share $ 0.45     $ 0.19     $ 0.17     $ 1.62
Normalized Funds From Operations Per Diluted Share $ 0.48     $ 0.63     $ 1.85     $ 2.25
                             

CORECIVIC, INC. AND SUBSIDIARIES
SUPPLEMENTAL FINANCIAL INFORMATION
(UNAUDITED AND AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

CALCULATION OF EBITDA AND ADJUSTED EBITDA

  For the Three Months Ended
December 31,
  For the Year Ended
December 31,
    2021     2020       2021       2020
               
Net income (loss) $ 28,037   $ (26,803 )   $ (51,896 )   $ 55,338
Interest expense   25,700     22,216       95,565       93,453
Depreciation and amortization   33,951     36,425       134,738       150,861
Income tax expense   9,331     1,203       137,999       4,386
EBITDA $ 97,019   $ 33,041     $ 316,406     $ 304,038
Expenses associated with debt repayments and refinancing transactions   4,112     7,141       56,279       7,141
Expenses associated with mergers and acquisitions                   338
Expenses associated with COVID-19       2,792       2,434       13,777
Expenses associated with changes in corporate tax structure       195             5,240
Contingent consideration for acquisition of businesses                   620
Loss (gain) on sale of real estate assets, net       17,943       (38,766 )     13,023
Shareholder litigation expense             54,295      
Asset impairments   2,027     47,570       11,378       60,628
Adjusted EBITDA $ 103,158   $ 108,682     $ 402,026     $ 404,805

GUIDANCE — CALCULATION OF FUNDS FROM OPERATIONS & EBITDA

  For the Year Ending
December 31, 2022
  Low End of
Guidance
High End of
Guidance
Net income $ 85,500 $ 102,750
Depreciation and amortization of real estate assets   98,500   99,000
Funds From Operations $ 184,000 $ 201,750
Diluted EPS $ 0.72 $ 0.86
FFO per diluted share $ 1.55 $ 1.70
     
Net income $ 85,500 $ 102,750
Interest expense   97,500   96,500
Depreciation and amortization   134,750   134,750
Income tax expense   37,000   36,000
EBITDA $ 354,750 $ 370,000

NOTE TO SUPPLEMENTAL FINANCIAL INFORMATION

Adjusted Net Income, EBITDA, Adjusted EBITDA, FFO, and Normalized FFO, and, where appropriate, their corresponding per share metrics are non-GAAP financial measures. The Company believes that these measures are important operating measures that supplement discussion and analysis of the Company’s results of operations and are used to review and assess operating performance of the Company and its properties and their management teams. The Company believes that it is useful to provide investors, lenders and security analysts disclosures of its results of operations on the same basis that is used by management.   FFO, in particular, is a widely accepted non-GAAP supplemental measure of performance of real estate companies, grounded in the standards for FFO established by the National Association of Real Estate Investment Trusts (NAREIT).

NAREIT defines FFO as net income computed in accordance with GAAP, excluding gains (or losses) from sales of property and extraordinary items, plus depreciation and amortization of real estate and impairment of depreciable real estate and after adjustments for unconsolidated partnerships and joint ventures calculated to reflect funds from operations on the same basis.   EBITDA, Adjusted EBITDA, and Normalized FFO are useful as supplemental measures of performance of the Company’s properties because such measures do not take into account depreciation and amortization, or with respect to EBITDA, the impact of the Company’s tax provisions and financing strategies. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), this accounting presentation assumes that the value of real estate assets diminishes at a level rate over time.   Because of the unique structure, design and use of the Company’s properties, management believes that assessing performance of the Company’s properties without the impact of depreciation or amortization is useful. The Company may make adjustments to FFO from time to time for certain other income and expenses that it considers non-recurring, infrequent or unusual, even though such items may require cash settlement, because such items do not reflect a necessary or ordinary component of the ongoing operations of the Company.   Normalized FFO excludes the effects of such items. The Company calculates Adjusted Net Income by adding to GAAP Net Income expenses associated with the Company’s debt repayments and refinancing transactions, and certain impairments and other charges that the Company believes are unusual or non-recurring to provide an alternative measure of comparing operating performance for the periods presented.

Other companies may calculate Adjusted Net Income, EBITDA, Adjusted EBITDA, FFO, and Normalized FFO differently than the Company does, or adjust for other items, and therefore comparability may be limited.   Adjusted Net Income, EBITDA, Adjusted EBITDA, FFO, and Normalized FFO and, where appropriate, their corresponding per share measures are not measures of performance under GAAP, and should not be considered as an alternative to cash flows from operating activities, a measure of liquidity or an alternative to net income as indicators of the Company’s operating performance or any other measure of performance derived in accordance with GAAP.   This data should be read in conjunction with the Company’s consolidated financial statements and related notes included in its filings with the Securities and Exchange Commission.

Contact:    Investors: Cameron Hopewell – Managing Director, Investor Relations – (615) 263-3024
      Financial Media: David Gutierrez, Dresner Corporate Services – (312) 780-7204

Beasley Broadcast Group (BBGI) – Solid Quarter; Favorable Revenue Momentum

Wednesday, February 09, 2022

Beasley Broadcast Group (BBGI)
Solid Quarter; Favorable Revenue Momentum

Beasley Broadcast Group Inc is a radio broadcasting company, engaged in operating radio stations throughout the United States. It operates radio stations including FM and AM radio stations located in large and mid-sized markets in the United States. The company owns and operates radio stations in the following radio markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, West Palm Beach-Boca Raton, FL, and Wilmington, DE. It is also a multi-platform, marketing solutions provider that offers on-air, online, and mobile and social media applications. The main source of revenue is the sale of advertising.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Patrick McCann, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Finishing strong. Fourth quarter 2021 revenues of $70.7 million was 2% above our forecast of $69.3 million. The revenues were better than the company’s guidance and reflected strong local spot revenue, up 14.4%, and national, up 9.2%, excluding Political. Digital revenues were up a strong 47%, accounting for 15% of total revenues, up from 13% in Q3. Adj. EBITDA of $9.4 million for the quarter beat our estimate of $8.7 million.

    Nearly recovered.  Q4 revenue was less than 2% below 2019 revenue, representing a nearly full recovery to pre-pandemic levels. One of the key factors that have helped drive revenue recovery has been the emergence of the sports betting advertising category ($4.3 million in the quarter) …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – electroCore – Data Presented at 2022 International Stroke Congress



Data Presented at 2022 International Stroke Congress Suggests Role for Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Stroke

News and Market Data on electroCore

 

Clinical Trial (n=69) suggests safety and feasibility of nVNS for the acute treatment of stroke.

Relative Ischemic Lesion Growth Decreased by 65.9% with nVNS vs. Sham Treatment.

ROCKAWAY, N.J.
Feb. 09, 2022 (GLOBE NEWSWIRE) — 
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced top line data from three abstracts being presented at the American Heart Associations’ 2022 
International Stroke Conference (
February 9-11, 2022
New Orleans) on the possible role of nVNS in the acute treatment of stroke.

The nVNS research presented at the 
International Stroke Conference 2022 includes:

Non-invasive Vagus Nerve Stimulation for The Acute Treatment of Ischemic or Hemorrhagic Stroke (TR-VENUS)

In this randomized, sham controlled, multi-center study conducted at nine academic centers in 
Turkey, the intent-to-treat (ITT) population included 69 subjects (61 ischemic stroke and eight intracerebral hemorrhage) distributed into three treatment arms: sham (n=25), standard-dose nVNS (7 stimulations over one hour; n=19), and high-dose nVNS (7 stimulations in hour 1 and hour 5; n=25). Every subject in the ITT population received all prespecified treatment stimulations per protocol and 97% of all randomized subjects in the study received their first stimulation less than 6 hours from stroke onset. The study met its primary objective with the composite primary safety endpoint being consistent across the three treatment arms indicating that nVNS was able to be administered safely in this acute stroke population. The study also met all secondary safety and feasibility endpoints. Relative infarct growth, measured by diffusion weighted imaging, in the high dose nVNS group (63.3%) was lower than in the sham group (185.8%; p=0.05) against baseline. Dr. Murat Arasava, one of the primary investigators of the TR-VENUS study and Professor of Neurology at the 
Hacettepe University in 
Ankara, Turkey commented, “We are pleased to have successfully completed this first trial of nVNS as a possible treatment for acute stroke and believe our data suggests that nVNS may be safe and feasible in both ischemic and hemorrhagic stroke. The efficacy signal suggested by the reduction in relative infarct growth rate in the ischemic population, which needs to be confirmed in larger studies, clearly provides the basis for additional research to further define the role for nVNS for the acute treatment of stroke.”

Non-invasive Vagus Nerve Stimulation in Acute Ischemic Stroke (NOVIS)

NOVIS is a prospective randomized clinical trial with blinded outcome assessment being conducted at the 
Leiden University Medical Center (Leiden, 
The Netherlands). 150 patients with ischemic stroke are being randomly allocated (1:1) to nVNS for five days in addition to standard treatment versus standard treatment alone. The primary endpoint is the final infarct volume on day five assessed with MRI. This study features a greater number of stimulations over five days than TR-VENUS, and advanced imaging endpoints including measurement of the penumbra, that should provide additional insight and clarity surrounding the role of nVNS for the acute treatment of ischemic stroke. Dr.  Anne van der Meij, from the 
Leiden University Medical Center, is presenting the poster at the 
International Stroke Conference and commented, “Our study is now more than 50% enrolled and our efficacy endpoints may provide greater definition, and possibly confirmation, of the efficacy of nVNS for the acute treatment of ischemic stroke.”

Effect Of Non-invasive Vagus Nerve Stimulation in Hemorrhagic Brain Injury and Permanent Ischemic Stroke in Rats

Dr.  Ilknur Ay of the 
Massachusetts General Hospital and 
Harvard Medical School presented the results of a pre-clinical study conducted in her lab at the 
Athinoula A. Martinos Center for Biomedical Imaging that supports prior evidence that nVNS may have therapeutic potential in ischemic stroke. The lack of adverse events in two different validated models of Intracerebral Hemorrhage in rats shown in this study suggests that nVNS could be safely administered as early as an ambulatory setting before the stroke etiology (ischemic vs. hemorrhagic) has been determined.

Stroke is ranked as the second leading cause of death worldwide with an annual mortality rate of about 5.5 million. The burden of stroke lies not only in its high mortality rate, but in the high morbidity rate as well with up to 50% of stroke survivors being chronically disabled. Stroke is a disease of immense public health importance with serious economic and social consequences. The public health burden of stroke is set to rise over future decades because of demographic transitions of populations across the world. According to the 
American Heart Association by 2030, 3.88% of the US population >18 years of age is projected to have had a stroke. Between 2012 and 2030, real (2010$) total direct annual stroke-related medical costs are expected to increase from 
$71.55 billion to 
$184.13 billion. Real indirect annual costs (attributable to lost productivity) are projected to rise from 
$33.65 billion to 
$56.54 billion over the same period. Overall, total annual costs of stroke are projected to increase to 
$240.67 billion by 2030, an increase of 129%.

Eric Liebler, Senior Vice President of Neurology for electroCore, commented, “We congratulate all of the investigators, patients and sites that have first in human study suggesting a role for nVNS in treatment of acute stroke. If effective, nVNS would represent a breakthrough treatment that could be safely deployed much earlier, more safely and more easily than current stroke treatments. As time to treatment is considered one of the most critical factors in the acute treatment of stroke, the ability to treat as early as in an ambulatory setting, before the type of stroke (ischemic or hemorrhagic) is confirmed by imaging, would represent a significant advance in the treatment of stroke. We look forward to the anticipated full publication of the TR-VENUS study in a peer reviewed journal later this year and the completion of the NOVIS study in 2023.”

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit www.electrocore.com.

About gammaCore™
gammaCore™ (nVNS) is the first non-invasive, hand-held medical therapy applied at the neck as an adjunctive therapy to treat migraine and cluster headache through the utilization of a mild electrical stimulation to the vagus nerve that passes through the skin. Designed as a portable, easy-to-use technology, gammaCore can be self-administered by patients, as needed, without the potential side effects associated with commonly prescribed drugs. When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers, which may lead to a reduction of pain in patients.

gammaCore (nVNS) is FDA cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, and the acute and preventive treatment of migraine in adolescent (ages 12 and older) and adult patients, and paroxysmal hemicrania and hemicrania continua in adult patients. gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache (Migraine, Cluster Headache, Trigeminal Autonomic Cephalalgias and Hemicrania Continua) and Medication Overuse Headache in adults.

gammaCore is contraindicated for patients if they:

  • Have an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device
  • Have a metallic device, such as a stent, bone plate, or bone screw, implanted at or near the neck
  • Are using another device at the same time (e.g., TENS Unit, muscle stimulator) or any portable electronic device (e.g., mobile phone)

Safety and efficacy of gammaCore have not been evaluated in the following patients:

  • Adolescent patients with congenital cardiac issues
  • Patients diagnosed with narrowing of the arteries (carotid atherosclerosis)
  • Patients who have had surgery to cut the vagus nerve in the neck (cervical vagotomy)
  • Pediatric patients (less than 12 years)
  • Pregnant women
  • Patients with clinically significant hypertension, hypotension, bradycardia, or tachycardia

For more information, please visit gammaCore.com

Forward-Looking Statements
This press release and other written and oral statements made by representatives of electroCore may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about electroCore’s business prospects and clinical and product development plans (including with respect to enrollment in ongoing studies); its pipeline or potential markets for its technologies; the timing, outcome and impact of regulatory, clinical and commercial developments; the issuance of 
U.S. and international patents providing expanded IP coverage; the possibility of future business models and revenue streams from the company’s potential use of nVNS for the acute treatment of stroke and hemorrhagic brain injury, the potential of nVNS generally and gammaCore in particular and other statements that are not historical in nature, particularly those that utilize terminology such as “anticipates,” “will,” “expects,” “believes,” “intends,” other words of similar meaning, derivations of such words and the use of future dates. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the ability to raise the additional funding needed to continue to pursue electroCore’s business and product development plans, the inherent uncertainties associated with developing new products or technologies, the ability to commercialize gammaCore™, the potential impact and effects of COVID-19 on the business of electroCore, electroCore’s results of operations and financial performance, and any measures electroCore has and may take in response to COVID-19 and any expectations electroCore may have with respect thereto, competition in the industry in which electroCore operates and overall market conditions. Any forward-looking statements are made as of the date of this press release, and electroCore assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents electroCore files with the 
SEC available at www.sec.gov.

Investors:
Rich Cockrell

CG Capital
404-736-3838
ecor@cg.capital

or

Media Contact:
Jackie Dorsky
electroCore
908-313-6331
jackie.dorsky@electrocore.com

FDA May Rethink Approving Drugs Tested in China


Phil & Pam Gladwell (Flickr)


FDA Oncology Director Expresses Concerns Over Applicability of Chinese Data

 

The Food and Drug Administration (FDA) will soon begin reviewing two dozen applications for cancer drugs. The trial data is based, in many cases, entirely on tests from mainland China. The U.S. regulator has begun expressing concerns about the quality of studies conducted in China and whether the results should even apply to patients in the U.S.

 

Background

Eli Lilly (LLY) has applied for a license to roll out a lung-cancer immunotherapy developed in China and sell it at a lower price than similar drugs now in the U.S. The application is for a drug called Sintilab, which is a PD-1 monoclonal antibody checkpoint inhibitor for non-small cell lung cancer. The FDA has concerns over the validity of test results. This could threaten the plan to bring the treatment to market later this year. How the FDA concerns translate into actions will become clearer after February 10th when they begin reviewing the data from Lilly’s Chinese partner, Innovent Biologics Inc. Lilly’s application is just the first of many applications to be considered by the agency, the decision is expected by late March.

The shift in thinking could stall or threaten applications from many large drugmakers, including Eli Lilly and Novartis, who stand to gain billions of dollars in sales from being the conduit for these medicines. It could also heighten trade tensions between the two countries.

 

“The elephant in the room is obviously, what is the quality of the data that is coming from these foreign countries?” Dr. Richard Pazdur, FDA

 

FDA Considerations

Richard Pazdur, director of the FDA’s Oncology Center of Excellence, has been quoted in academic and medical literature about his new concerns regarding “me-too” drugs coming from China and the fundamental challenges they pose to the agency’s drug approval criteria. This includes whether results, provided primarily from test subjects in China, are applicable to Americans, and the validity of the data. Pazdur has said, “We have nothing against drugs being developed in China. Our issue is, are those results generalizable to the U.S. population?”

Clinical trials, especially extensive, late-stage studies that regulators review to decide whether to approve a new drug, are among the highest research and development expenses. Industry executives are watching to see if the newer mindset leads to delays or outright FDA rejections of increased efforts to bring a pipeline of treatments to American patients from abroad. Perhaps measures and additional assessments of benefits and safety profiles on different populations will be needed in the future. Dr. Pazdur has expressed when drugs are tested only or primarily in one country such as China, it is difficult to assess whether the drug would have the same benefits and safety profile in the U.S. population. Dr. Pazdur also said he was concerned the Chinese studies used outdated study designs, which don’t directly establish whether the China-developed drug works, as well as similar drugs, approved in the U.S.

There are also concerns that go beyond the applicability of the data. Dr. Pazdur has also shown concern about the integrity of data generated by drug studies in China. According to the British Medical Journal, an analysis by Chinese regulators in 2016 found that about 80% of domestic drug applications reviewed at that time, contained fabricated, flawed, or insufficient data in the studies – in some cases, there were discrepancies between original study data and what was submitted to regulators.

 

Take-Away

A growing trend of large drugmakers partnering with testing labs in China as part of an application for U.S. FDA approval may be faced with an FDA, that had once been friendly to the idea, but now has openly changed its tone. The new thinking seems to be, that there may be differences in medical care and populations that affect how a drug performs.

This could impact two dozen applications before the FDA. A final agency decision on whether to clear the Lilly/Innovent treatment is expected by the end of March.

Paul Hoffman

Managing Editor, Channelchek

 

Suggested Reading



Understanding the FDA Medical Device Approval Pathways Helps Investors



Immunotherapy to Treat Cancer May Involve Placing Cancer Cells in the Body





Therapeutic Research Advanced by Stem Cell Science



Imugene (IUGNF) – Three Innovative Platforms That Could Change Cancer Treatment

 

Source

https://www.fda.gov/media/156021/download

https://www.statnews.com/2022/02/04/fda-richard-pazdur-cancer-drug-eli-lilly-china/

https://endpts.com/appearing-to-walk-back-fdas-openness-to-foreign-trials-pazdur-suggests-eli-lillys-pd-1-will-face-tough-road-ahead/

https://cancerletter.com/conversation-with-the-cancer-letter/20220204_1/

https://www.wsj.com/articles/fda-raises-concerns-about-china-developed-drugs-11644408180?mod=Searchresults_pos1&page=1

https://www.nejm.org/doi/full/10.1056/NEJMp2116863

 

Stay up to date. Follow us:

 

Kratos Defense Security (KTOS) – Business Continues To Come In

Wednesday, February 09, 2022

Kratos Defense & Security (KTOS)
Business Continues To Come In

Kratos Defense & Security Solutions is a National Security technology provider with proprietary expertise in the area of unmanned aerial vehicles, electronics for missile defense systems, electronic warfare systems, satellite control and management systems and support services for emerging naval weapon systems. Commercial and state and local government revenues are about 25% of the total and comprise primarily of critical infrastructure monitoring and protection systems.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    $50 Million Award. Yesterday, Kratos announced the receipt of an approximately $50 million contract value increase from a National Security customer for an existing C5ISR program. Kratos supplies the customer with specialized products, hardware, engineering and other services and deliverables.

    And $15 Million for Drone Support.  Kratos also received approximately $15 million in contract awards for logistics support, spares, consumables, and support needed for the growing demand for Kratos’ customer drone system operations. The awards are a reflection of the pent-up demand for increased operational missions, which should bode well for Kratos …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Beasley Broadcast Group (BBGI) – Solid Quarter Favorable Revenue Momentum

Wednesday, February 09, 2022

Beasley Broadcast Group (BBGI)
Solid Quarter; Favorable Revenue Momentum

Beasley Broadcast Group Inc is a radio broadcasting company, engaged in operating radio stations throughout the United States. It operates radio stations including FM and AM radio stations located in large and mid-sized markets in the United States. The company owns and operates radio stations in the following radio markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, West Palm Beach-Boca Raton, FL, and Wilmington, DE. It is also a multi-platform, marketing solutions provider that offers on-air, online, and mobile and social media applications. The main source of revenue is the sale of advertising.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Patrick McCann, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Finishing strong. Fourth quarter 2021 revenues of $70.7 million was 2% above our forecast of $69.3 million. The revenues were better than the company’s guidance and reflected strong local spot revenue, up 14.4%, and national, up 9.2%, excluding Political. Digital revenues were up a strong 47%, accounting for 15% of total revenues, up from 13% in Q3. Adj. EBITDA of $9.4 million for the quarter beat our estimate of $8.7 million.

    Nearly recovered.  Q4 revenue was less than 2% below 2019 revenue, representing a nearly full recovery to pre-pandemic levels. One of the key factors that have helped drive revenue recovery has been the emergence of the sports betting advertising category ($4.3 million in the quarter) …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.